{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:25:58Z","timestamp":1792671958660,"version":"4.5.0"},"reference-count":357,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2025JJ60646"],"award-info":[{"award-number":["2025JJ60646"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2023JJ40485"],"award-info":[{"award-number":["2023JJ40485"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2023JJ60471"],"award-info":[{"award-number":["2023JJ60471"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003824","name":"Hunan University","doi-asserted-by":"publisher","award":["2024XJZB002"],"award-info":[{"award-number":["2024XJZB002"]}],"id":[{"id":"10.13039\/501100003824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82474133"],"award-info":[{"award-number":["82474133"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82274159"],"award-info":[{"award-number":["82274159"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009377","name":"Education Department of Hunan Province","doi-asserted-by":"publisher","award":["23B0387"],"award-info":[{"award-number":["23B0387"]}],"id":[{"id":"10.13039\/100009377","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009377","name":"Education Department of Hunan Province","doi-asserted-by":"publisher","award":["22B0355"],"award-info":[{"award-number":["22B0355"]}],"id":[{"id":"10.13039\/100009377","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002664","name":"Hunan Normal University","doi-asserted-by":"publisher","award":["202329-2"],"award-info":[{"award-number":["202329-2"]}],"id":[{"id":"10.13039\/501100002664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.metabol.2025.156436","type":"journal-article","created":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T05:47:49Z","timestamp":1763185669000},"page":"156436","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Targeting lipid metabolism in neurodegenerative diseases: From experimental to clinical"],"prefix":"10.1016","volume":"175","author":[{"given":"Junpeng","family":"Long","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shasha","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaning","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanjuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qidi","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"37","key":"10.1016\/j.metabol.2025.156436_bb0005","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adc9317","article-title":"Brain lipidomics: from functional landscape to clinical significance","volume":"8","author":"Yoon","year":"2022","journal-title":"Sci Adv"},{"key":"10.1016\/j.metabol.2025.156436_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.yfrne.2021.100899","article-title":"Brain lipidomics as a rising field in neurodegenerative contexts: perspectives with Machine Learning approaches","volume":"61","author":"Castellanos","year":"2021","journal-title":"Front Neuroendocrinol"},{"key":"10.1016\/j.metabol.2025.156436_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2023.101235","article-title":"Lipid metabolism around the body clocks","volume":"91","author":"Petrenko","year":"2023","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.metabol.2025.156436_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2022.101165","article-title":"Polyunsaturated fatty acids and fatty acid-derived lipid mediators: recent advances in the understanding of their biosynthesis, structures, and functions","volume":"86","author":"Dyall","year":"2022","journal-title":"Prog Lipid Res"},{"issue":"5","key":"10.1016\/j.metabol.2025.156436_bb0025","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nrm.2017.138","article-title":"Understanding the diversity of membrane lipid composition","volume":"19","author":"Harayama","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7","key":"10.1016\/j.metabol.2025.156436_bb0030","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028035","article-title":"Pathology of neurodegenerative diseases","volume":"9","author":"Dugger","year":"2017","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"Suppl","key":"10.1016\/j.metabol.2025.156436_bb0035","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1038\/nm1066","article-title":"Protein aggregation and neurodegenerative disease","volume":"210","author":"Ross","year":"2004","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.metabol.2025.156436_bb0040","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1161\/CIRCRESAHA.122.319951","article-title":"Post-stroke cognitive impairment and dementia","volume":"130","author":"Rost","year":"2022","journal-title":"Circ Res"},{"issue":"4","key":"10.1016\/j.metabol.2025.156436_bb0045","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa1304839","article-title":"Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer\u2019s disease","volume":"370","author":"Salloway","year":"2014","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.metabol.2025.156436_bb0050","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/s41593-020-00778-1","article-title":"Gene-based therapies for neurodegenerative diseases","volume":"24","author":"Sun","year":"2021","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.metabol.2025.156436_bb0055","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2015.56","article-title":"Alzheimer\u2019s disease","volume":"1","author":"Masters","year":"2015","journal-title":"Nat Rev Dis Primers"},{"issue":"10","key":"10.1016\/j.metabol.2025.156436_bb0060","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41582-019-0244-7","article-title":"Ageing as a risk factor for neurodegenerative disease","volume":"15","author":"Hou","year":"2019","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"10.1016\/j.metabol.2025.156436_bb0065","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.tem.2022.01.007","article-title":"Targeting aging mechanisms: pharmacological perspectives","volume":"33","author":"Moskalev","year":"2022","journal-title":"Trends Endocrinol Metab"},{"issue":"8016","key":"10.1016\/j.metabol.2025.156436_bb0070","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41586-024-07516-8","article-title":"Senescent glia link mitochondrial dysfunction and lipid accumulation","volume":"630","author":"Byrns","year":"2024","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.metabol.2025.156436_bb0075","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.3390\/biom14111362","article-title":"Exploring the dynamic changes of brain lipids, lipid rafts, and lipid droplets in aging and Alzheimer\u2019s disease","volume":"14","author":"Cerasuolo","year":"2024","journal-title":"Biomolecules"},{"issue":"6","key":"10.1016\/j.metabol.2025.156436_bb0080","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1111\/febs.16344","article-title":"Lipid metabolism and Alzheimer\u2019s disease: clinical evidence, mechanistic link and therapeutic promise","volume":"290","author":"Yin","year":"2023","journal-title":"FEBS J"},{"issue":"4","key":"10.1016\/j.metabol.2025.156436_bb0085","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.immuni.2024.03.010","article-title":"Innate immune activation in neurodegenerative diseases","volume":"57","author":"Castro-Gomez","year":"2024","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.metabol.2025.156436_bb0090","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/jnc.15834","article-title":"Fundamental neurochemistry review: old brain stories - influence of age and sex on the neurodegeneration-associated lipid changes","volume":"166","author":"Cuenca-Bermejo","year":"2023","journal-title":"J Neurochem"},{"key":"10.1016\/j.metabol.2025.156436_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2024.106505","article-title":"Targeting dysregulated lipid metabolism for the treatment of Alzheimer\u2019s disease and Parkinson\u2019s disease: current advancements and future prospects","volume":"196","author":"Tong","year":"2024","journal-title":"Neurobiol Dis"},{"issue":"1","key":"10.1016\/j.metabol.2025.156436_bb0100","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3390\/ijms25010131","article-title":"Lipids as Emerging Biomarkers in Neurodegenerative Diseases","volume":"25","author":"Wei","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"5\u20136","key":"10.1016\/j.metabol.2025.156436_bb0105","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1159\/000502576","article-title":"Charcot and cholesterin","volume":"81","author":"Walusinski","year":"2019","journal-title":"Eur Neurol"},{"key":"10.1016\/j.metabol.2025.156436_bb0110","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.4158\/EP-2020-0347","article-title":"Cholesterol review: a metabolically important molecule","author":"Schade","year":"2020","journal-title":"Endocr Pract"},{"issue":"6","key":"10.1016\/j.metabol.2025.156436_bb0115","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/cr.2008.61","article-title":"Feedback regulation of cholesterol synthesis: sterol-accelerated ubiquitination and degradation of HMG CoA reductase","volume":"18","author":"DeBose-Boyd","year":"2008","journal-title":"Cell Res"},{"key":"10.1016\/j.metabol.2025.156436_bb0120","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.mam.2014.02.001","article-title":"Cross-talk between liver and intestine in control of cholesterol and energy homeostasis","volume":"37","author":"Groen","year":"2014","journal-title":"Mol Aspects Med"},{"issue":"8","key":"10.1016\/j.metabol.2025.156436_bb0125","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/iub.2662","article-title":"Central nervous system cholesterol metabolism in health and disease","volume":"74","author":"Ho","year":"2022","journal-title":"IUBMB Life"},{"issue":"1","key":"10.1016\/j.metabol.2025.156436_bb0130","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1038\/s41467-023-42179-5","article-title":"Bile acids-mediated intracellular cholesterol transport promotes intestinal cholesterol absorption and NPC1L1 recycling","volume":"14","author":"Xiao","year":"2023","journal-title":"Nat Commun"},{"issue":"16\u201318","key":"10.1016\/j.metabol.2025.156436_bb0135","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1089\/ars.2024.0674","article-title":"Cholesterol metabolism in neurodegenerative diseases","volume":"41","author":"He","year":"2024","journal-title":"Antioxid Redox Signal"},{"issue":"5","key":"10.1016\/j.metabol.2025.156436_bb0140","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.tins.2022.01.002","article-title":"Brain cell type-specific cholesterol metabolism and implications for learning and memory","volume":"45","author":"Li","year":"2022","journal-title":"Trends Neurosci"},{"issue":"1","key":"10.1016\/j.metabol.2025.156436_bb0145","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13024-022-00542-y","article-title":"TREM2 in the pathogenesis of AD: a lipid metabolism regulator and potential metabolic therapeutic target","volume":"17","author":"Li","year":"2022","journal-title":"Mol Neurodegener"},{"issue":"4","key":"10.1016\/j.metabol.2025.156436_bb0150","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s13238-014-0131-3","article-title":"Cholesterol metabolism and homeostasis in the brain","volume":"6","author":"Zhang","year":"2015","journal-title":"Protein Cell"},{"key":"10.1016\/j.metabol.2025.156436_bb0155","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1146\/annurev-neuro-091922-034237","article-title":"Cholesterol metabolism in aging and age-related disorders","volume":"46","author":"Saher","year":"2023","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.metabol.2025.156436_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2023.105635","article-title":"Brain cholesterol homeostasis and its association with neurodegenerative diseases","volume":"171","author":"Gao","year":"2023","journal-title":"Neurochem Int"},{"issue":"48","key":"10.1016\/j.metabol.2025.156436_bb0165","doi-asserted-by":"crossref","first-page":"30178","DOI":"10.1074\/jbc.272.48.30178","article-title":"Importance of a novel oxidative mechanism for elimination of brain cholesterol. Turnover of cholesterol and 24(S)-hydroxycholesterol in rat brain as measured with 18O2 techniques in vivo and in vitro","volume":"272","author":"Bj\u00f6rkhem","year":"1997","journal-title":"J Biol Chem"},{"issue":"9","key":"10.1016\/j.metabol.2025.156436_bb0170","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1007\/s11095-021-03098-6","article-title":"Interactions of lipids, lipoproteins, and apolipoproteins with the blood-brain barrier","volume":"38","author":"Rhea","year":"2021","journal-title":"Pharm Res"},{"key":"10.1016\/j.metabol.2025.156436_bb0175","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3389\/fncel.2019.00212","article-title":"Lipid metabolism crosstalk in the brain: glia and neurons","volume":"13","author":"Barber","year":"2019","journal-title":"Front Cell Neurosci"},{"issue":"48","key":"10.1016\/j.metabol.2025.156436_bb0180","doi-asserted-by":"crossref","first-page":"34414","DOI":"10.1074\/jbc.M113.508812","article-title":"Differential phospholipid substrates and directional transport by ATP-binding cassette proteins ABCA1, ABCA7, and ABCA4 and disease-causing mutants","volume":"288","author":"Quazi","year":"2013","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.metabol.2025.156436_bb0185","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.neuron.2014.08.005","article-title":"More than cholesterol transporters: lipoprotein receptors in CNS function and neurodegeneration","volume":"83","author":"Lane-Donovan","year":"2014","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.metabol.2025.156436_bb0190","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1093\/brain\/awae018","article-title":"Elevated cholesterol in ATAD3 mutants is a compensatory mechanism that leads to membrane cholesterol aggregation","volume":"147","author":"Mu\u00f1oz-Oreja","year":"2024","journal-title":"Brain"},{"issue":"16","key":"10.1016\/j.metabol.2025.156436_bb0195","doi-asserted-by":"crossref","first-page":"5886","DOI":"10.1073\/pnas.0308456101","article-title":"Genetic evidence for nonredundant functional cooperativity between NPC1 and NPC2 in lipid transport","volume":"101","author":"Sleat","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2025.156436_bb0200","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.semcdb.2020.07.016","article-title":"Lipids in regulating oligodendrocyte structure and function","volume":"112","author":"Montani","year":"2021","journal-title":"Semin Cell Dev Biol"},{"issue":"4","key":"10.1016\/j.metabol.2025.156436_bb0205","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/nn1426","article-title":"High cholesterol level is essential for myelin membrane growth","volume":"8","author":"Saher","year":"2005","journal-title":"Nat Neurosci"},{"issue":"4","key":"10.1016\/j.metabol.2025.156436_bb0210","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.cmet.2015.02.016","article-title":"Lack of sterol regulatory element binding factor-1c imposes glial Fatty Acid utilization leading to peripheral neuropathy","volume":"21","author":"Cermenati","year":"2015","journal-title":"Cell Metab"},{"issue":"20","key":"10.1016\/j.metabol.2025.156436_bb0215","doi-asserted-by":"crossref","first-page":"10130","DOI":"10.1073\/pnas.1821306116","article-title":"Gene expression in oligodendrocytes during remyelination reveals cholesterol homeostasis as a therapeutic target in multiple sclerosis","volume":"116","author":"Voskuhl","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.metabol.2025.156436_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109889","article-title":"Neuronal cholesterol synthesis is essential for repair of chronically demyelinated lesions in mice","volume":"37","author":"Berghoff","year":"2021","journal-title":"Cell Rep"},{"issue":"10","key":"10.1016\/j.metabol.2025.156436_bb0225","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1038\/s41593-024-01749-6","article-title":"Oligodendroglial fatty acid metabolism as a central nervous system energy reserve","volume":"27","author":"Asadollahi","year":"2024","journal-title":"Nat Neurosci"},{"issue":"1","key":"10.1016\/j.metabol.2025.156436_bb0230","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13024-020-0358-9","article-title":"Therapeutic approaches targeting Apolipoprotein E function in Alzheimer\u2019s disease","volume":"15","author":"Williams","year":"2020","journal-title":"Mol Neurodegener"},{"issue":"6","key":"10.1016\/j.metabol.2025.156436_bb0235","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.neuron.2021.01.005","article-title":"Astrocytic ApoE reprograms neuronal cholesterol metabolism and histone-acetylation-mediated memory","volume":"109","author":"Li","year":"2021","journal-title":"Neuron"},{"issue":"6","key":"10.1016\/j.metabol.2025.156436_bb0240","first-page":"746","article-title":"Dysregulation of cholesterol balance in the brain: contribution to neurodegenerative diseases","volume":"5","author":"Vance","year":"2012","journal-title":"Dis Model Mech"},{"issue":"20","key":"10.1016\/j.metabol.2025.156436_bb0245","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1016\/j.neuron.2023.07.005","article-title":"Neuronal \u03b3-secretase regulates lipid metabolism, linking cholesterol to synaptic dysfunction in Alzheimer\u2019s disease","volume":"111","author":"Essayan-Perez","year":"2023","journal-title":"Neuron"},{"key":"10.1016\/j.metabol.2025.156436_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.sbi.2022.102369","article-title":"Structural enzymology of cholesterol biosynthesis and storage","volume":"74","author":"Long","year":"2022","journal-title":"Curr Opin Struct Biol"},{"issue":"4","key":"10.1016\/j.metabol.2025.156436_bb0255","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adj1354","article-title":"CYP46A1-mediated cholesterol turnover induces sex-specific changes in cognition and counteracts memory loss in ovariectomized mice","volume":"10","author":"Latorre-Leal","year":"2024","journal-title":"Sci Adv"},{"issue":"28","key":"10.1016\/j.metabol.2025.156436_bb0260","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adi4746","article-title":"27-Hydroxycholesterol acts on estrogen receptor \u03b1 expressed by POMC neurons in the arcuate nucleus to modulate feeding behavior","volume":"10","author":"Ye","year":"2024","journal-title":"Sci Adv"},{"issue":"1","key":"10.1016\/j.metabol.2025.156436_bb0265","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/jnc.12275","article-title":"24(S)-hydroxycholesterol is actively eliminated from neuronal cells by ABCA1","volume":"126","author":"Matsuda","year":"2013","journal-title":"J Neurochem"},{"issue":"8","key":"10.1016\/j.metabol.2025.156436_bb0270","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/s41574-018-0037-x","article-title":"Liver X receptors in lipid signalling and membrane homeostasis","volume":"14","author":"Wang","year":"2018","journal-title":"Nat Rev Endocrinol"},{"issue":"Pt 8","key":"10.1016\/j.metabol.2025.156436_bb0275","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1093\/brain\/awv166","article-title":"CYP46A1 inhibition, brain cholesterol accumulation and neurodegeneration pave the way for Alzheimer\u2019s disease","volume":"138","author":"Djelti","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.metabol.2025.156436_bb0280","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.696778","article-title":"Cholesterol hydroxylating cytochrome P450 46A1: from mechanisms of action to clinical applications","volume":"13","author":"Pikuleva","year":"2021","journal-title":"Front Aging Neurosci"},{"issue":"1 Suppl","key":"10.1016\/j.metabol.2025.156436_bb0285","first-page":"18S","article-title":"Functional roles of fatty acids and their effects on human health","volume":"39","author":"Calder","year":"2015","journal-title":"JPEN J Parenter Enteral Nutr"},{"issue":"12","key":"10.1016\/j.metabol.2025.156436_bb0290","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084871","article-title":"A more desirable balanced polyunsaturated fatty acid composition achieved by heterologous expression of \u039415\/\u03944 desaturases in mammalian cells","volume":"8","author":"Zhu","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.metabol.2025.156436_bb0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.plipres.2013.10.002","article-title":"Long-chain polyunsaturated fatty acids (LCPUFA) from genesis to senescence: the influence of LCPUFA on neural development, aging, and neurodegeneration","volume":"53","author":"Janssen","year":"2014","journal-title":"Prog Lipid Res"},{"issue":"5","key":"10.1016\/j.metabol.2025.156436_bb0300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0096503","article-title":"Enhanced production of docosahexaenoic acid in mammalian cells","volume":"9","author":"Zhu","year":"2014","journal-title":"PloS One"},{"issue":"5","key":"10.1016\/j.metabol.2025.156436_bb0305","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1042\/BST20160474","article-title":"Omega-3 fatty acids and inflammatory processes: from molecules to man","volume":"45","author":"Calder","year":"2017","journal-title":"Biochem Soc Trans"},{"issue":"1 Suppl 1","key":"10.1016\/j.metabol.2025.156436_bb0310","first-page":"S153","article-title":"Oral administration of circulating precursors for membrane phosphatides can promote the synthesis of new brain synapses","volume":"4","author":"Cansev","year":"2008","journal-title":"Alzheimers Dement"},{"issue":"3","key":"10.1016\/j.metabol.2025.156436_bb0315","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3390\/nu8030128","article-title":"An increase in the omega-6\/omega-3 fatty acid ratio increases the risk for obesity","volume":"8","author":"Simopoulos","year":"2016","journal-title":"Nutrients"},{"key":"10.1016\/j.metabol.2025.156436_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2024.101289","article-title":"Impact of dietary n-6\/n-3 fatty acid ratio of atherosclerosis risk: a review","volume":"95","author":"Cao","year":"2024","journal-title":"Prog Lipid Res"},{"issue":"2","key":"10.1016\/j.metabol.2025.156436_bb0325","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.plipres.2007.12.004","article-title":"The opposing effects of n\u22123 and n\u22126 fatty acids","volume":"47","author":"Schmitz","year":"2008","journal-title":"Prog Lipid Res"},{"issue":"5","key":"10.1016\/j.metabol.2025.156436_bb0330","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.tibs.2016.02.003","article-title":"Intermediates of metabolism: from bystanders to signalling molecules","volume":"41","author":"Haas","year":"2016","journal-title":"Trends Biochem Sci"},{"issue":"3","key":"10.1016\/j.metabol.2025.156436_bb0335","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.3168\/jds.S0022-0302(05)72780-6","article-title":"Endogenous production of n\u22123 and n\u22126 fatty acids in mammalian cells","volume":"88","author":"Morimoto","year":"2005","journal-title":"J Dairy Sci"},{"issue":"1","key":"10.1016\/j.metabol.2025.156436_bb0340","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1124\/pr.117.014092","article-title":"Anti-inflammatory effects of omega-3 fatty acids in the brain: physiological mechanisms and relevance to pharmacology","volume":"70","author":"Lay\u00e9","year":"2018","journal-title":"Pharmacol Rev"},{"issue":"6","key":"10.1016\/j.metabol.2025.156436_bb0345","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.plipres.2009.07.002","article-title":"Alpha-linolenic acid and its conversion to longer chain n-3 fatty acids: benefits for human health and a role in maintaining tissue n-3 fatty acid levels","volume":"48","author":"Barcel\u00f3-Coblijn","year":"2009","journal-title":"Prog Lipid Res"},{"issue":"2\u20133","key":"10.1016\/j.metabol.2025.156436_bb0350","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s12035-010-8139-z","article-title":"Omega-3 essential fatty acids modulate initiation and progression of neurodegenerative disease","volume":"41","author":"Palacios-Pelaez","year":"2010","journal-title":"Mol Neurobiol"},{"issue":"7501","key":"10.1016\/j.metabol.2025.156436_bb0355","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nature13324","article-title":"Mfsd2a is critical for the formation and function of the blood-brain barrier","volume":"509","author":"Ben-Zvi","year":"2014","journal-title":"Nature"},{"issue":"7872","key":"10.1016\/j.metabol.2025.156436_bb0360","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/s41586-021-03782-y","article-title":"Structure and mechanism of blood-brain-barrier lipid transporter MFSD2A","volume":"596","author":"Wood","year":"2021","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.metabol.2025.156436_bb0365","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.neuron.2017.03.043","article-title":"Blood-brain barrier permeability is regulated by lipid transport-dependent suppression of caveolae-mediated transcytosis","volume":"94","author":"Andreone","year":"2017","journal-title":"Neuron"},{"issue":"6","key":"10.1016\/j.metabol.2025.156436_bb0370","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1007\/s11064-022-03564-6","article-title":"Ginsenoside Rg1 plays a neuroprotective role in regulating the iron-regulated proteins and against lipid peroxidation in oligodendrocytes","volume":"47","author":"Chen","year":"2022","journal-title":"Neurochem Res"},{"issue":"6","key":"10.1016\/j.metabol.2025.156436_bb0375","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20211314","article-title":"CD36, a signaling receptor and fatty acid transporter that regulates immune cell metabolism and fate","volume":"219","author":"Chen","year":"2022","journal-title":"J Exp Med"},{"issue":"5","key":"10.1016\/j.metabol.2025.156436_bb0380","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.cmet.2017.08.024","article-title":"The glia-neuron lactate shuttle and elevated ROS promote lipid synthesis in neurons and lipid droplet accumulation in glia via APOE\/D","volume":"26","author":"Liu","year":"2017","journal-title":"Cell Metab"},{"issue":"11","key":"10.1016\/j.metabol.2025.156436_bb0385","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1011475","article-title":"Neuronal fatty acid-binding protein enhances autophagy and suppresses amyloid-\u03b2 pathology in a Drosophila model of Alzheimer\u2019s disease","volume":"20","author":"Jang","year":"2024","journal-title":"PLoS Genet"},{"issue":"2","key":"10.1016\/j.metabol.2025.156436_bb0390","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/med.21712","article-title":"Mitochondria and lipid peroxidation in the mechanism of neurodegeneration: finding ways for prevention","volume":"41","author":"Angelova","year":"2021","journal-title":"Med Res Rev"},{"issue":"12","key":"10.1016\/j.metabol.2025.156436_bb0395","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nrn3820","article-title":"Polyunsaturated fatty acids and their metabolites in brain function and disease","volume":"15","author":"Bazinet","year":"2014","journal-title":"Nat Rev Neurosci"},{"issue":"3","key":"10.1016\/j.metabol.2025.156436_bb0400","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.3390\/ijms24032116","article-title":"Dihomo-\u03b3-linolenic acid (20:3n\u22126)-metabolism, derivatives, and potential significance in chronic inflammation","volume":"24","author":"Mustonen","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"12","key":"10.1016\/j.metabol.2025.156436_bb0405","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.3390\/biom11121873","article-title":"Essential fatty acids and their metabolites in the pathobiology of inflammation and its resolution","volume":"11","author":"Das","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.metabol.2025.156436_bb0410","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s42003-019-0521-4","article-title":"Multi-omic analysis in transgenic mice implicates omega-6\/omega-3 fatty acid imbalance as a risk factor for chronic disease","volume":"2","author":"Kaliannan","year":"2019","journal-title":"Commun Biol"},{"issue":"8","key":"10.1016\/j.metabol.2025.156436_bb0415","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/s42255-023-00835-6","article-title":"Fatty acid oxidation organizes mitochondrial supercomplexes to sustain astrocytic ROS and cognition","volume":"5","author":"Morant-Ferrando","year":"2023","journal-title":"Nat Metab"},{"issue":"11","key":"10.1016\/j.metabol.2025.156436_bb0420","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2022111901","article-title":"Mitochondrial morphology controls fatty acid utilization by changing CPT1 sensitivity to malonyl-CoA","volume":"42","author":"Ngo","year":"2023","journal-title":"EMBO J"},{"issue":"7","key":"10.1016\/j.metabol.2025.156436_bb0425","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.freeradbiomed.2011.06.027","article-title":"Lipid peroxidation and neurodegenerative disease","volume":"51","author":"Reed","year":"2011","journal-title":"Free Radic Biol Med"},{"issue":"6","key":"10.1016\/j.metabol.2025.156436_bb0430","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1172\/JCI63967","article-title":"Malonyl-CoA: the regulator of fatty acid synthesis and oxidation","volume":"122","author":"Foster","year":"2012","journal-title":"J Clin Invest"},{"issue":"11","key":"10.1016\/j.metabol.2025.156436_bb0435","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1016\/j.bbadis.2018.08.028","article-title":"cPLA2 and desaturases underlie the tau hyperphosphorylation offset induced by BACE knock-down in neuronal primary cultures","volume":"1864","author":"Villamil-Ortiz","year":"2018","journal-title":"Biochim Biophys Acta Mol basis Dis"},{"issue":"5","key":"10.1016\/j.metabol.2025.156436_bb0440","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20191660","article-title":"Stearoyl-CoA desaturase-1 impairs the reparative properties of macrophages and microglia in the brain","volume":"217","author":"Bogie","year":"2020","journal-title":"J Exp Med"},{"issue":"Pt 1","key":"10.1016\/j.metabol.2025.156436_bb0445","article-title":"Buddlejasaponin IVb ameliorates ferroptosis of dopaminergic neuron by suppressing IRP2-mediated iron overload in Parkinson\u2019s disease","volume":"319","author":"Li","year":"2024","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.metabol.2025.156436_bb0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.118363","article-title":"Ganoderic acid A mitigates dopaminergic neuron ferroptosis via inhibiting NCOA4-mediated ferritinophagy in Parkinson\u2019s disease mice","volume":"332","author":"Li","year":"2024","journal-title":"J Ethnopharmacol"},{"issue":"10","key":"10.1016\/j.metabol.2025.156436_bb0455","article-title":"Boosting microglial lipid metabolism via TREM2 signaling by biomimetic nanoparticles to attenuate the sevoflurane-induced developmental neurotoxicity","volume":"11","author":"Li","year":"2024","journal-title":"Adv Sci (Weinh)"},{"issue":"6","key":"10.1016\/j.metabol.2025.156436_bb0460","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.cmet.2024.03.014","article-title":"Microglial lipid droplet accumulation in tauopathy brain is regulated by neuronal AMPK","volume":"36","author":"Li","year":"2024","journal-title":"Cell Metab"},{"issue":"8","key":"10.1016\/j.metabol.2025.156436_bb0465","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.cmet.2021.07.006","article-title":"Astrocyte-neuron metabolic cooperation shapes brain activity","volume":"33","author":"Bonvento","year":"2021","journal-title":"Cell Metab"},{"issue":"1\u20132","key":"10.1016\/j.metabol.2025.156436_bb0470","first-page":"177","article-title":"Glial lipid droplets and ROS induced by mitochondrial defects promote neurodegeneration","volume":"160","author":"Liu","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.metabol.2025.156436_bb0475","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.neuint.2017.03.018","article-title":"Brain energy metabolism spurns fatty acids as fuel due to their inherent mitotoxicity and potential capacity to unleash neurodegeneration","volume":"109","author":"Sch\u00f6nfeld","year":"2017","journal-title":"Neurochem Int"},{"issue":"6","key":"10.1016\/j.metabol.2025.156436_bb0480","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.cell.2019.04.001","article-title":"Neuron-astrocyte metabolic coupling protects against activity-induced fatty acid toxicity","volume":"177","author":"Ioannou","year":"2019","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.metabol.2025.156436_bb0485","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/s42255-023-00756-4","article-title":"Loss of fatty acid degradation by astrocytic mitochondria triggers neuroinflammation and neurodegeneration","volume":"5","author":"Mi","year":"2023","journal-title":"Nat Metab"},{"issue":"12","key":"10.1016\/j.metabol.2025.156436_bb0490","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.3390\/nu14122406","article-title":"Age-associated glia remodeling and mitochondrial dysfunction in neurodegeneration: antioxidant supplementation as a possible intervention","volume":"14","author":"Picca","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.metabol.2025.156436_bb0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2022.101162","article-title":"Sphingolipid control of cognitive functions in health and disease","volume":"86","author":"Kalinichenko","year":"2022","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.metabol.2025.156436_bb0500","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.semcdb.2020.10.008","article-title":"Sphingolipids metabolism alteration in the central nervous system: amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases","volume":"112","author":"Bouscary","year":"2021","journal-title":"Semin Cell Dev Biol"},{"issue":"10","key":"10.1016\/j.metabol.2025.156436_bb0505","doi-asserted-by":"crossref","DOI":"10.1111\/cns.70082","article-title":"Exploratory analysis of the association between plasma ceramide alterations and cognitive dysfunction in Parkinson\u2019s disease","volume":"30","author":"Liu","year":"2024","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.metabol.2025.156436_bb0510","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.156041","article-title":"Jiawei Xionggui Decoction promotes meningeal lymphatic vessels clearance of \u03b2-amyloid by inhibiting arachidonic acid pathway","volume":"135","author":"Liu","year":"2024","journal-title":"Phytomedicine"},{"issue":"12","key":"10.1016\/j.metabol.2025.156436_bb0515","doi-asserted-by":"crossref","first-page":"3901","DOI":"10.1161\/STROKEAHA.120.033414","article-title":"Serum sphingosine-1-phosphate levels are associated with severity and outcome in patients with cerebral ischemia","volume":"52","author":"Schwedhelm","year":"2021","journal-title":"Stroke"},{"issue":"10","key":"10.1016\/j.metabol.2025.156436_bb0520","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1007\/s11655-024-3666-z","article-title":"Berberine inhibits ferroptosis and stabilizes atherosclerotic plaque through NRF2\/SLC7A11\/GPX4 pathway","volume":"30","author":"Wang","year":"2024","journal-title":"Chin J Integr Med"},{"issue":"1","key":"10.1016\/j.metabol.2025.156436_bb0525","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3892\/mmr.2023.13139","article-title":"Notoginsenoside R1 ameliorates the inflammation induced by amyloid-\u03b2 by suppressing SphK1-mediated NF-\u03baB activation in PC12 cells","volume":"29","author":"Wang","year":"2024","journal-title":"Mol Med Rep"},{"issue":"3","key":"10.1016\/j.metabol.2025.156436_bb0530","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1007\/s12035-015-9136-z","article-title":"GM1 ganglioside: past studies and future potential","volume":"53","author":"Aureli","year":"2016","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.metabol.2025.156436_bb0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101298","article-title":"Role of hypothalamic de novo ceramides synthesis in obesity and associated metabolic disorders","volume":"53","author":"Magnan","year":"2021","journal-title":"Mol Metab"},{"issue":"12","key":"10.1016\/j.metabol.2025.156436_bb0540","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2023.168000","article-title":"Role of ceramides and sphingolipids in Parkinson\u2019s disease","volume":"435","author":"Vos","year":"2023","journal-title":"J Mol Biol"},{"issue":"10","key":"10.1016\/j.metabol.2025.156436_bb0545","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13954","article-title":"Alterations of lipid-mediated mitophagy result in aging-dependent sensorimotor defects","volume":"22","author":"Oleinik","year":"2023","journal-title":"Aging Cell"},{"key":"10.1016\/j.metabol.2025.156436_bb0550","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111099","article-title":"Ceramides and mitochondrial homeostasis","volume":"117","author":"Ding","year":"2024","journal-title":"Cell Signal"},{"issue":"6463","key":"10.1016\/j.metabol.2025.156436_bb0555","doi-asserted-by":"crossref","DOI":"10.1126\/science.aar5551","article-title":"Sphingosine 1-phosphate: lipid signaling in pathology and therapy","volume":"366","author":"Cartier","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.metabol.2025.156436_bb0560","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.116471","article-title":"Study on the action mechanism of Buyang Huanwu Decoction against ischemic stroke based on S1P\/S1PR1\/PI3K\/Akt signaling pathway","volume":"312","author":"Liu","year":"2023","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.metabol.2025.156436_bb0565","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cca.2021.06.020","article-title":"Sphingosine 1-phosphate and its receptors in ischemia","volume":"521","author":"Lu","year":"2021","journal-title":"Clin Chim Acta"},{"issue":"5","key":"10.1016\/j.metabol.2025.156436_bb0570","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.cmet.2023.03.022","article-title":"Very-long-chain fatty acids induce glial-derived sphingosine-1-phosphate synthesis, secretion, and neuroinflammation","volume":"35","author":"Chung","year":"2023","journal-title":"Cell Metab"},{"issue":"15","key":"10.1016\/j.metabol.2025.156436_bb0575","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.3390\/nu15153456","article-title":"Underlying mechanisms of brain aging and neurodegenerative diseases as potential targets for preventive or therapeutic strategies using phytochemicals","volume":"15","author":"Abdolmaleky","year":"2023","journal-title":"Nutrients"},{"issue":"10284","key":"10.1016\/j.metabol.2025.156436_bb0580","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer\u2019s disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.metabol.2025.156436_bb0585","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13024-022-00566-4","article-title":"APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer\u2019s disease pathology and brain diseases","volume":"17","author":"Fern\u00e1ndez-Calle","year":"2022","journal-title":"Mol Neurodegener"},{"issue":"4","key":"10.1016\/j.metabol.2025.156436_bb0590","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.cmet.2018.05.019","article-title":"Phospholipase PLA2G6, a Parkinsonism-associated gene, affects Vps26 and Vps35, retromer function, and ceramide levels, similar to \u03b1-synuclein gain","volume":"28","author":"Lin","year":"2018","journal-title":"Cell Metab"},{"issue":"6","key":"10.1016\/j.metabol.2025.156436_bb0595","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.neuron.2018.05.008","article-title":"APOE4 causes widespread molecular and cellular alterations associated with Alzheimer\u2019s disease phenotypes in human iPSC-derived brain cell types","volume":"98","author":"Lin","year":"2018","journal-title":"Neuron"},{"issue":"8","key":"10.1016\/j.metabol.2025.156436_bb0600","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.neuron.2022.03.004","article-title":"ApoE cascade hypothesis in the pathogenesis of Alzheimer\u2019s disease and related dementias","volume":"110","author":"Martens","year":"2022","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.metabol.2025.156436_bb0605","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13024-020-00413-4","article-title":"APOE2: protective mechanism and therapeutic implications for Alzheimer\u2019s disease","volume":"15","author":"Li","year":"2020","journal-title":"Mol Neurodegener"},{"issue":"6","key":"10.1016\/j.metabol.2025.156436_bb0610","doi-asserted-by":"crossref","first-page":"708","DOI":"10.2174\/1568026616666160617090227","article-title":"Rexinoids as therapeutics for Alzheimer\u2019s disease: role of APOE","volume":"17","author":"Koster","year":"2017","journal-title":"Curr Top Med Chem"},{"issue":"8","key":"10.1016\/j.metabol.2025.156436_bb0615","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.stem.2022.07.005","article-title":"Lipid accumulation induced by APOE4 impairs microglial surveillance of neuronal-network activity","volume":"29","author":"Victor","year":"2022","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.metabol.2025.156436_bb0620","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13024-024-00772-2","article-title":"Proteomic analysis of APOE\u03b54 carriers implicates lipid metabolism, complement and lymphocyte signaling in cognitive resilience","volume":"19","author":"Walker","year":"2024","journal-title":"Mol Neurodegener"},{"issue":"12","key":"10.1016\/j.metabol.2025.156436_bb0625","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1002\/alz.12362","article-title":"Population estimate of people with clinical Alzheimer\u2019s disease and mild cognitive impairment in the United States (2020-2060)","volume":"17","author":"Rajan","year":"2021","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.metabol.2025.156436_bb0630","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s40478-019-0729-z","article-title":"APOE genotype and sex affect microglial interactions with plaques in Alzheimer\u2019s disease mice","volume":"7","author":"Stephen","year":"2019","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"10.1016\/j.metabol.2025.156436_bb0635","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13024-022-00574-4","article-title":"ApoE in Alzheimer\u2019s disease: pathophysiology and therapeutic strategies","volume":"17","author":"Raulin","year":"2022","journal-title":"Mol Neurodegener"},{"issue":"5","key":"10.1016\/j.metabol.2025.156436_bb0640","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/nrn3012","article-title":"Linking lipids to Alzheimer\u2019s disease: cholesterol and beyond","volume":"212","author":"Di Paolo","year":"2011","journal-title":"Nat Rev Neurosci"},{"issue":"9","key":"10.1016\/j.metabol.2025.156436_bb0645","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.ejim.2015.08.012","article-title":"Do statins prevent Alzheimer\u2019s disease? A narrative review","volume":"26","author":"Daneschvar","year":"2015","journal-title":"Eur J Intern Med"},{"issue":"3","key":"10.1016\/j.metabol.2025.156436_bb0650","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.stem.2018.12.013","article-title":"Cholesterol metabolism is a druggable axis that independently regulates tau and amyloid-\u03b2 in iPSC-derived Alzheimer\u2019s disease neurons","volume":"24","author":"van der Kant","year":"2019","journal-title":"Cell Stem Cell"},{"issue":"5","key":"10.1016\/j.metabol.2025.156436_bb0655","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1093\/brain\/awae028","article-title":"Brain cholesterol and Alzheimer\u2019s disease: challenges and opportunities in probe and drug development","volume":"147","author":"Ahmed","year":"2024","journal-title":"Brain"},{"issue":"7937","key":"10.1016\/j.metabol.2025.156436_bb0660","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/s41586-022-05439-w","article-title":"APOE4 impairs myelination via cholesterol dysregulation in oligodendrocytes","volume":"611","author":"Blanchard","year":"2022","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.metabol.2025.156436_bb0665","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.3233\/JAD-160467","article-title":"ABCA1 Agonist Reverses the ApoE4-Driven Cognitive and Brain Pathologies","volume":"54","author":"Boehm-Cagan","year":"2016","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"10.1016\/j.metabol.2025.156436_bb0670","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/alz.12220","article-title":"ABCA7 and the altered lipidostasis hypothesis of Alzheimer\u2019s disease","volume":"17","author":"Lyssenko","year":"2021","journal-title":"Alzheimers Dement"},{"issue":"3","key":"10.1016\/j.metabol.2025.156436_bb0675","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.neuron.2023.10.023","article-title":"Amelioration of Tau and ApoE4-linked glial lipid accumulation and neurodegeneration with an LXR agonist","volume":"112","author":"Litvinchuk","year":"2024","journal-title":"Neuron"},{"issue":"12","key":"10.1016\/j.metabol.2025.156436_bb0680","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/j.devcel.2024.03.030","article-title":"Accumulation of APP C-terminal fragments causes endolysosomal dysfunction through the dysregulation of late endosome to lysosome-ER contact sites","volume":"59","author":"Bretou","year":"2024","journal-title":"Dev Cell"},{"issue":"583","key":"10.1016\/j.metabol.2025.156436_bb0685","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaz4564","article-title":"APOE4 disrupts intracellular lipid homeostasis in human iPSC-derived glia","volume":"13","author":"Sienski","year":"2021","journal-title":"Sci Transl Med"},{"issue":"9","key":"10.1016\/j.metabol.2025.156436_bb0690","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1002\/alz.12121","article-title":"Apolipoprotein E4 disrupts the neuroprotective action of sortilin in neuronal lipid metabolism and endocannabinoid signaling","volume":"16","author":"Asaro","year":"2020","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.metabol.2025.156436_bb0695","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.neuron.2007.08.008","article-title":"Amyloid precursor protein regulates brain apolipoprotein E and cholesterol metabolism through lipoprotein receptor LRP1","volume":"56","author":"Liu","year":"2007","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.metabol.2025.156436_bb0700","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.neuron.2019.12.007","article-title":"TREM2 regulates microglial cholesterol metabolism upon chronic phagocytic challenge","volume":"105","author":"Nugent","year":"2020","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.metabol.2025.156436_bb0705","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s12974-017-0920-8","article-title":"Sexually divergent induction of microglial-associated neuroinflammation with hippocampal aging","volume":"14","author":"Mangold","year":"2017","journal-title":"J Neuroinflammation"},{"issue":"8","key":"10.1016\/j.metabol.2025.156436_bb0710","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1038\/mt.2013.118","article-title":"Acat1 knockdown gene therapy decreases amyloid-\u03b2 in a mouse model of Alzheimer\u2019s disease","volume":"21","author":"Murphy","year":"2013","journal-title":"Mol Ther"},{"issue":"1","key":"10.1016\/j.metabol.2025.156436_bb0715","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/s41467-022-28769-9","article-title":"ATAD3A oligomerization promotes neuropathology and cognitive deficits in Alzheimer\u2019s disease models","volume":"13","author":"Zhao","year":"2022","journal-title":"Nat Commun"},{"issue":"24","key":"10.1016\/j.metabol.2025.156436_bb0720","doi-asserted-by":"crossref","first-page":"6820","DOI":"10.1016\/j.cell.2024.09.036","article-title":"PLD3 and PLD4 synthesize S,S-BMP, a key phospholipid enabling lipid degradation in lysosomes","volume":"187","author":"Singh","year":"2024","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.metabol.2025.156436_bb0725","doi-asserted-by":"crossref","first-page":"5197","DOI":"10.1038\/s41467-023-40927-1","article-title":"Microglial REV-ERB\u03b1 regulates inflammation and lipid droplet formation to drive tauopathy in male mice","volume":"14","author":"Lee","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.metabol.2025.156436_bb0730","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2024.106747","article-title":"Serum metabolome profiling in patients with mild cognitive impairment reveals sex differences in lipid metabolism","volume":"204","author":"Escarcega","year":"2025","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.metabol.2025.156436_bb0735","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev-pathmechdis-031521-034145","article-title":"Genetics and pathogenesis of Parkinson\u2019s syndrome","volume":"18","author":"Ye","year":"2023","journal-title":"Annu Rev Pathol"},{"issue":"4","key":"10.1016\/j.metabol.2025.156436_bb0740","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s00018-022-04240-2","article-title":"Initiation and progression of \u03b1-synuclein pathology in Parkinson\u2019s disease","volume":"79","author":"Tofaris","year":"2022","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"10.1016\/j.metabol.2025.156436_bb0745","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s40035-023-00368-8","article-title":"Animal models of Parkinson\u2019s disease: bridging the gap between disease hallmarks and research questions","volume":"12","author":"Dovonou","year":"2023","journal-title":"Transl Neurodegener"},{"key":"10.1016\/j.metabol.2025.156436_bb0750","article-title":"Disease burden of Parkinson\u2019s disease in China and its provinces from 1990 to 2021: findings from the global burden of disease study 2021","volume":"46","author":"Xu","year":"2024","journal-title":"Lancet Reg Health West Pac"},{"issue":"Pt 1","key":"10.1016\/j.metabol.2025.156436_bb0755","article-title":"Neuroprotective mechanisms of defatted walnut powder against scopolamine-induced Alzheimer\u2019s disease in mice revealed through metabolomics and proteomics analyses","volume":"319","author":"Xu","year":"2024","journal-title":"J Ethnopharmacol"},{"issue":"4","key":"10.1016\/j.metabol.2025.156436_bb0760","doi-asserted-by":"crossref","DOI":"10.1172\/JCI180478","article-title":"PINK1 is a target of T cell responses in Parkinson\u2019s disease","volume":"135","author":"Williams","year":"2024","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2025.156436_bb0765","doi-asserted-by":"crossref","DOI":"10.1016\/j.bpc.2023.107122","article-title":"The interaction between alpha-synuclein and mitochondrial dysfunction in Parkinson\u2019s disease","volume":"303","author":"Li","year":"2023","journal-title":"Biophys Chem"},{"issue":"1","key":"10.1016\/j.metabol.2025.156436_bb0770","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41531-024-00645-x","article-title":"Large-scale proteomics analysis of five brain regions from Parkinson\u2019s disease patients with a GBA1 mutation","volume":"10","author":"Blumenreich","year":"2024","journal-title":"NPJ Parkinsons Dis"},{"issue":"2","key":"10.1016\/j.metabol.2025.156436_bb0775","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0166-2236(97)01188-0","article-title":"Modification of ion homeostasis by lipid peroxidation: roles in neuronal degeneration and adaptive plasticity","volume":"21","author":"Mattson","year":"1998","journal-title":"Trends Neurosci"},{"issue":"4","key":"10.1016\/j.metabol.2025.156436_bb0780","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0896-6273(03)00024-2","article-title":"The formation of highly soluble oligomers of alpha-synuclein is regulated by fatty acids and enhanced in Parkinson\u2019s disease","volume":"37","author":"Sharon","year":"2003","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.metabol.2025.156436_bb0785","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0896-6273(03)00024-2","article-title":"The formation of highly soluble oligomers of alpha-synuclein is regulated by fatty acids and enhanced in Parkinson\u2019s disease","volume":"237","author":"Sharon","year":"2003","journal-title":"Neuron"},{"issue":"8","key":"10.1016\/j.metabol.2025.156436_bb0790","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1093\/brain\/awad137","article-title":"Epsin2, a novel target for multiple system atrophy therapy via \u03b1-synuclein\/FABP7 propagation","volume":"146","author":"Cheng","year":"2023","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.metabol.2025.156436_bb0795","article-title":"Plasma metabolomics profiles indicate sex differences of lipid metabolism in patients with Parkinson\u2019s disease","volume":"14","author":"Hu","year":"2024"},{"issue":"5","key":"10.1016\/j.metabol.2025.156436_bb0800","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.molcel.2018.11.028","article-title":"Lipidomic analysis of \u03b1-synuclein neurotoxicity identifies stearoyl CoA desaturase as a target for Parkinson treatment","volume":"73","author":"Fanning","year":"2019","journal-title":"Mol Cell"},{"issue":"3","key":"10.1016\/j.metabol.2025.156436_bb0805","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1007\/s13311-022-01199-7","article-title":"A Brain-Penetrant Stearoyl-CoA Desaturase Inhibitor Reverses \u03b1-Synuclein Toxicity","volume":"19","author":"Nuber","year":"2022","journal-title":"Neurotherapeutics"},{"issue":"7","key":"10.1016\/j.metabol.2025.156436_bb0810","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.tcb.2024.01.010","article-title":"Driving factors of neuronal ferroptosis","volume":"34","author":"Jacquemyn","year":"2024","journal-title":"Trends Cell Biol"},{"issue":"3","key":"10.1016\/j.metabol.2025.156436_bb0815","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/brain\/awab371","article-title":"Sphingolipid changes in Parkinson L444P GBA mutation fibroblasts promote \u03b1-synuclein aggregation","volume":"145","author":"Galvagnion","year":"2022","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.metabol.2025.156436_bb0820","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/mds.25729","article-title":"Altered ceramide acyl chain length and ceramide synthase gene expression in Parkinson\u2019s disease","volume":"29","author":"Abbott","year":"2014","journal-title":"Mov Disord"},{"issue":"43","key":"10.1016\/j.metabol.2025.156436_bb0825","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2025347118","article-title":"Ceramide accumulation induces mitophagy and impairs \u03b2-oxidation in PINK1 deficiency","volume":"118","author":"Vos","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Pt 7","key":"10.1016\/j.metabol.2025.156436_bb0830","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1093\/brain\/awv132","article-title":"Loss of PLA2G6 leads to elevated mitochondrial lipid peroxidation and mitochondrial dysfunction","volume":"138","author":"Kinghorn","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.metabol.2025.156436_bb0835","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3389\/fphar.2020.00077","article-title":"Sphingosine-1-phosphate receptors modulators decrease signs of neuroinflammation and prevent Parkinson\u2019s disease symptoms in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model","volume":"11","author":"P\u00e9pin","year":"2020","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.metabol.2025.156436_bb0840","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13024-019-0355-z","article-title":"Correction to: reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson\u2019s disease","volume":"15","author":"Huebecker","year":"2020","journal-title":"Mol Neurodegener"},{"issue":"11","key":"10.1016\/j.metabol.2025.156436_bb0845","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/mds.29577","article-title":"27-hydroxycholesterol drives the spread of \u03b1-synuclein pathology in Parkinson\u2019s disease","volume":"38","author":"Dai","year":"2023","journal-title":"Mov Disord"},{"issue":"5","key":"10.1016\/j.metabol.2025.156436_bb0850","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nchembio782","article-title":"Elevated levels of oxidized cholesterol metabolites in Lewy body disease brains accelerate alpha-synuclein fibrilization","volume":"2","author":"Bosco","year":"2006","journal-title":"Nat Chem Biol"},{"issue":"11","key":"10.1016\/j.metabol.2025.156436_bb0855","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1074\/jbc.RA118.005639","article-title":"24(S),25-Epoxycholesterol and cholesterol 24S-hydroxylase (CYP46A1) overexpression promote midbrain dopaminergic neurogenesis in vivo","volume":"294","author":"Theofilopoulos","year":"2019","journal-title":"J Biol Chem"},{"issue":"10446","key":"10.1016\/j.metabol.2025.156436_bb0860","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1016\/S0140-6736(24)00642-1","volume":"403","author":"Hilkens","year":"2024","journal-title":"Stroke Lancet"},{"issue":"3","key":"10.1016\/j.metabol.2025.156436_bb0865","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1001\/jamaneurol.2021.5080","article-title":"Association of ischemic stroke incidence, severity, and recurrence with dementia in the atherosclerosis risk in communities cohort study","volume":"79","author":"Koton","year":"2022","journal-title":"JAMA Neurol"},{"issue":"2","key":"10.1016\/j.metabol.2025.156436_bb0870","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.mcna.2018.10.001","article-title":"Cerebrovascular disease: primary and secondary stroke prevention","volume":"103","author":"Caprio","year":"2019","journal-title":"Med Clin North Am"},{"issue":"21","key":"10.1016\/j.metabol.2025.156436_bb0875","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1161\/CIRCULATIONAHA.116.024261","article-title":"Plasma ceramides, mediterranean diet, and incident cardiovascular disease in the PREDIMED Trial (Prevenci\u00f3n con Dieta Mediterr\u00e1nea)","volume":"135","author":"Wang","year":"2017","journal-title":"Circulation"},{"issue":"20","key":"10.1016\/j.metabol.2025.156436_bb0880","doi-asserted-by":"crossref","first-page":"10074","DOI":"10.7150\/thno.61646","article-title":"Sult2b1 deficiency exacerbates ischemic stroke by promoting pro-inflammatory macrophage polarization in mice","volume":"11","author":"Wang","year":"2021","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.metabol.2025.156436_bb0885","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa1910355","article-title":"A comparison of two LDL cholesterol targets after ischemic stroke","volume":"382","author":"Amarenco","year":"2020","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.metabol.2025.156436_bb0890","doi-asserted-by":"crossref","DOI":"10.1172\/JCI128114","article-title":"Aberrant oligodendroglial LDL receptor orchestrates demyelination in chronic cerebral ischemia","volume":"131","author":"Xie","year":"2021","journal-title":"J Clin Invest"},{"issue":"9","key":"10.1016\/j.metabol.2025.156436_bb0895","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.jacc.2009.12.072","article-title":"Stroke prevention and treatment","volume":"56","author":"Marsh","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.metabol.2025.156436_bb0900","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12916-021-02014-4","article-title":"The risk of ischemic stroke and hemorrhagic stroke in Chinese adults with low-density lipoprotein cholesterol concentrations <70mg\/dL","volume":"19","author":"Wu","year":"2021","journal-title":"BMC Med"},{"issue":"10","key":"10.1016\/j.metabol.2025.156436_bb0905","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1161\/ATVBAHA.118.310792","article-title":"Estrogen inhibits LDL (low-density lipoprotein) transcytosis by human coronary artery endothelial cells via GPER (G-protein-coupled estrogen receptor) and SR-BI (scavenger receptor class B type 1)","volume":"38","author":"Ghaffari","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.metabol.2025.156436_bb0910","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.yhbeh.2018.10.010","article-title":"Sex hormones and stroke: beyond estrogens","volume":"111","author":"Sohrabji","year":"2019","journal-title":"Horm Behav"},{"issue":"1","key":"10.1016\/j.metabol.2025.156436_bb0915","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.1038\/s41467-018-05806-0","article-title":"Apolipoprotein A-IV binds \u03b1IIb\u03b23 integrin and inhibits thrombosis","volume":"9","author":"Xu","year":"2018","journal-title":"Nat Commun"},{"issue":"14","key":"10.1016\/j.metabol.2025.156436_bb0920","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1161\/CIRCULATIONAHA.108.782300","article-title":"Activation of liver X receptors promotes neuroprotection and reduces brain inflammation in experimental stroke","volume":"118","author":"Morales","year":"2008","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.metabol.2025.156436_bb0925","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.tins.2011.03.003","article-title":"Supply and demand for endocannabinoids","volume":"34","author":"Alger","year":"2011","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.metabol.2025.156436_bb0930","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2022.101194","article-title":"Anandamide and other N-acylethanolamines: a class of signaling lipids with therapeutic opportunities","volume":"89","author":"Mock","year":"2023","journal-title":"Prog Lipid Res"},{"issue":"6855","key":"10.1016\/j.metabol.2025.156436_bb0935","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/35097089","article-title":"An endogenous cannabinoid (2-AG) is neuroprotective after brain injury","volume":"413","author":"Panikashvili","year":"2001","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.metabol.2025.156436_bb0940","doi-asserted-by":"crossref","first-page":"4220","DOI":"10.1038\/s41467-021-24469-y","article-title":"Prokineticin-2 prevents neuronal cell deaths in a model of traumatic brain injury","volume":"12","author":"Bao","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.metabol.2025.156436_bb0945","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.mam.2018.09.003","article-title":"Docosanoids and elovanoids from omega-3 fatty acids are pro-homeostatic modulators of inflammatory responses, cell damage and neuroprotection","volume":"64","author":"Bazan","year":"2018","journal-title":"Mol Aspects Med"},{"issue":"2","key":"10.1016\/j.metabol.2025.156436_bb0950","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1161\/CIRCRESAHA.107.154443","article-title":"Polyunsaturated fatty acids are cerebral vasodilators via the TREK-1 potassium channel","volume":"101","author":"Blondeau","year":"2007","journal-title":"Circ Res"},{"issue":"11","key":"10.1016\/j.metabol.2025.156436_bb0955","first-page":"3130","article-title":"n\u22123 docosapentaenoic acid-derived protectin D1 promotes resolution of neuroinflammation and arrests epileptogenesis","volume":"141","author":"Frigerio","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.metabol.2025.156436_bb0960","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1146\/annurev.pathmechdis.3.121806.151409","article-title":"Anti-inflammatory and proresolving lipid mediators","volume":"3","author":"Serhan","year":"2008","journal-title":"Annu Rev Pathol"},{"issue":"9","key":"10.1016\/j.metabol.2025.156436_bb0965","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1700735","article-title":"Elovanoids are a novel class of homeostatic lipid mediators that protect neural cell integrity upon injury","volume":"3","author":"Bhattacharjee","year":"2017","journal-title":"Sci Adv"},{"issue":"2","key":"10.1016\/j.metabol.2025.156436_bb0970","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nm1362","article-title":"Prostaglandin E2 EP1 receptors: downstream effectors of COX-2 neurotoxicity","volume":"12","author":"Kawano","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.metabol.2025.156436_bb0975","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jare.2023.08.007","article-title":"Lipidomic analysis identifies long-chain acylcarnitine as a target for ischemic stroke","volume":"61","author":"Huang","year":"2024","journal-title":"J Adv Res"},{"key":"10.1016\/j.metabol.2025.156436_bb0980","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2025.156161","article-title":"Ceramides increase mitochondrial permeabilization to trigger mtDNA-dependent inflammation in astrocytes during brain ischemia","volume":"166","author":"Huang","year":"2025","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.metabol.2025.156436_bb0985","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12906-025-04751-y","article-title":"UHPLC-Q Exactive-Orbitrap-MS and network pharmacology analyses to investigate the mechanism by which Danggui-Shaoyao-San affects 27-OHC-induced cell damage in SH-SY5Y\/C6 coculture","volume":"25","author":"Huang","year":"2025","journal-title":"BMC Complement Med Ther"},{"issue":"7","key":"10.1016\/j.metabol.2025.156436_bb0990","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.7150\/thno.71029","article-title":"Neuronal STAT3\/HIF-1\u03b1\/PTRF axis-mediated bioenergetic disturbance exacerbates cerebral ischemia-reperfusion injury via PLA2G4A","volume":"12","author":"Jin","year":"2022","journal-title":"Theranostics"},{"issue":"19","key":"10.1016\/j.metabol.2025.156436_bb0995","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1016\/j.neuron.2023.06.024","article-title":"PLA2G2E-mediated lipid metabolism triggers brain-autonomous neural repair after ischemic stroke","volume":"111","author":"Nakamura","year":"2023","journal-title":"Neuron"},{"key":"10.1016\/j.metabol.2025.156436_bb1000","article-title":"Signaling roles of sphingolipids in the ischemic brain and their potential utility as therapeutic targets","volume":"201","author":"Mohamud","year":"2024","journal-title":"Neurobiol Dis"},{"issue":"6","key":"10.1016\/j.metabol.2025.156436_bb1005","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3390\/genes15060807","article-title":"Beyond CAG repeats: the multifaceted role of genetics in Huntington disease","volume":"15","author":"Pengo","year":"2024","journal-title":"Genes (Basel)"},{"issue":"10","key":"10.1016\/j.metabol.2025.156436_bb1010","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/s41582-020-0389-4","article-title":"Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities","volume":"16","author":"Tabrizi","year":"2020","journal-title":"Nat Rev Neurol"},{"issue":"22","key":"10.1016\/j.metabol.2025.156436_bb1015","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242216154","article-title":"Uncovering the genetic and molecular features of Huntington\u2019s disease in Northern Colombia","volume":"24","author":"Ahmad","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.metabol.2025.156436_bb1020","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2023.101224","article-title":"Sphingolipids and impaired hypoxic stress responses in Huntington disease","volume":"90","author":"Burtscher","year":"2023","journal-title":"Prog Lipid Res"},{"issue":"10","key":"10.1016\/j.metabol.2025.156436_bb1025","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1093\/brain\/awab186","article-title":"SREBP2 gene therapy targeting striatal astrocytes ameliorates Huntington's disease phenotypes","volume":"144","author":"Birolini","year":"2021","journal-title":"Brain"},{"issue":"17","key":"10.1016\/j.metabol.2025.156436_bb1030","doi-asserted-by":"crossref","first-page":"7927","DOI":"10.1073\/pnas.1002924107","article-title":"SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis","volume":"107","author":"Luthi-Carter","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Pt 11","key":"10.1016\/j.metabol.2025.156436_bb1035","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1093\/brain\/awn212","article-title":"Plasma 24S-hydroxycholesterol and caudate MRI in pre-manifest and early Huntington\u2019s disease","volume":"131","author":"Leoni","year":"2008","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.metabol.2025.156436_bb1040","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1038\/s42255-023-00873-0","article-title":"A defect in mitochondrial fatty acid synthesis impairs iron metabolism and causes elevated ceramide levels","volume":"5","author":"Dutta","year":"2023","journal-title":"Nat Metab"},{"key":"10.1016\/j.metabol.2025.156436_bb1045","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1196\/annals.1427.018","article-title":"Mitochondria and Huntington\u2019s disease pathogenesis: insight from genetic and chemical models","volume":"1147","author":"Browne","year":"2008","journal-title":"Ann N Y Acad Sci"},{"issue":"11","key":"10.1016\/j.metabol.2025.156436_bb1050","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.15252\/emmm.201707763","article-title":"Disease-modifying effects of ganglioside GM1 in Huntington\u2019s disease models","volume":"9","author":"Alpaugh","year":"2017","journal-title":"EMBO Mol Med"},{"issue":"1","key":"10.1016\/j.metabol.2025.156436_bb1055","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ymthe.2022.09.004","article-title":"Treatment with THI, an inhibitor of sphingosine-1-phosphate lyase, modulates glycosphingolipid metabolism and results therapeutically effective in experimental models of Huntington\u2019s disease","volume":"31","author":"Pepe","year":"2023","journal-title":"Mol Ther"},{"issue":"10","key":"10.1016\/j.metabol.2025.156436_bb1060","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/ene.14393","article-title":"Amyotrophic lateral sclerosis: a clinical review","volume":"27","author":"Masrori","year":"2020","journal-title":"Eur J Neurol"},{"issue":"4","key":"10.1016\/j.metabol.2025.156436_bb1065","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40478-015-0271-6","article-title":"Early and gender-specific differences in spinal cord mitochondrial function and oxidative stress markers in a mouse model of ALS","volume":"13","author":"Cacabelos","year":"2016","journal-title":"Acta Neuropathol Commun"},{"issue":"21\u221222","key":"10.1016\/j.metabol.2025.156436_bb1070","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1101\/gad.315564.118","article-title":"A C9orf72-CARM1 axis regulates lipid metabolism under glucose starvation-induced nutrient stress","volume":"32","author":"Liu","year":"2018","journal-title":"Genes Dev"},{"issue":"3","key":"10.1016\/j.metabol.2025.156436_bb1075","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/brain\/awae270","article-title":"Dysregulation of muscle cholesterol transport in amyotrophic lateral sclerosis","volume":"148","author":"Sapaly","year":"2025","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.metabol.2025.156436_bb1080","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/biof.1597","article-title":"The effects of statins on microglial cells to protect against neurodegenerative disorders: a mechanistic review","volume":"46","author":"Bagheri","year":"2020","journal-title":"Biofactors"},{"issue":"3","key":"10.1016\/j.metabol.2025.156436_bb1085","first-page":"592","article-title":"Identification of new mutations in the Cu\/Zn superoxide dismutase gene of patients with familial amyotrophic lateral sclerosis","volume":"56","author":"Pramatarova","year":"1995","journal-title":"Am J Hum Genet"},{"issue":"9","key":"10.1016\/j.metabol.2025.156436_bb1090","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1001\/jamaneurol.2014.1214","article-title":"Dietary \u03c9\u22123 polyunsaturated fatty acid intake and risk for amyotrophic lateral sclerosis","volume":"71","author":"Fitzgerald","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.metabol.2025.156436_bb1095","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.720672","article-title":"Association of plasma metabolic biomarker sphingosine-1-phosphate with cerebral collateral circulation in acute ischemic stroke","volume":"12","author":"Yu","year":"2021","journal-title":"Front Physiol"},{"issue":"7","key":"10.1016\/j.metabol.2025.156436_bb1100","doi-asserted-by":"crossref","first-page":"e690","DOI":"10.1212\/WNL.0000000000207485","article-title":"Association of polyunsaturated fatty acids and clinical progression in patients with ALS: post hoc analysis of the EMPOWER trial","volume":"101","author":"Bjornevik","year":"2023","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.metabol.2025.156436_bb1105","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/ana.24936","article-title":"Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: a more than 20-year follow-up of the Swedish AMORIS cohort","volume":"81","author":"Mariosa","year":"2017","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.metabol.2025.156436_bb1110","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41531-021-00241-3","article-title":"Glucosylceramide in cerebrospinal fluid of patients with GBA-associated and idiopathic Parkinson\u2019s disease enrolled in PPMI","volume":"7","author":"Huh","year":"2021","journal-title":"NPJ Parkinsons Dis"},{"issue":"4","key":"10.1016\/j.metabol.2025.156436_bb1115","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1007\/s12035-021-02688-0","article-title":"Impaired sphingolipid hydrolase activities in dementia with Lewy bodies and multiple system atrophy","volume":"59","author":"Usenko","year":"2022","journal-title":"Mol Neurobiol"},{"issue":"1","key":"10.1016\/j.metabol.2025.156436_bb1120","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s13195-023-01359-7","article-title":"Lipidomics profiling reveals distinct patterns of plasma sphingolipid alterations in Alzheimer\u2019s disease and vascular dementia","volume":"15","author":"Chua","year":"2023","journal-title":"Alzheimers Res Ther"},{"issue":"5","key":"10.1016\/j.metabol.2025.156436_bb1125","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1002\/alz.13792","article-title":"The shift in the fatty acid composition of the circulating lipidome in Alzheimer\u2019s disease","volume":"20","author":"Dakterzada","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"12","key":"10.1016\/j.metabol.2025.156436_bb1130","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1136\/jnnp-2020-323611","article-title":"Untargeted metabolomics yields insight into ALS disease mechanisms","volume":"91","author":"Goutman","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"10.1016\/j.metabol.2025.156436_bb1135","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.celrep.2012.05.001","article-title":"A dysregulated endocannabinoid-eicosanoid network supports pathogenesis in a mouse model of Alzheimer\u2019s disease","volume":"1","author":"Piro","year":"2012","journal-title":"Cell Rep"},{"issue":"9","key":"10.1016\/j.metabol.2025.156436_bb1140","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1096\/fj.04-3010fje","article-title":"A role for endocannabinoids in the generation of parkinsonism and levodopa-induced dyskinesia in MPTP-lesioned non-human primate models of Parkinson\u2019s disease","volume":"19","author":"van der Stelt","year":"2005","journal-title":"FASEB J"},{"issue":"3","key":"10.1016\/j.metabol.2025.156436_bb1145","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/j.1471-4159.2010.06964.x","article-title":"Cerebellar lipid differences between R6\/1 transgenic mice and humans with Huntington\u2019s disease","volume":"115","author":"Denny","year":"2010","journal-title":"J Neurochem"},{"issue":"1","key":"10.1016\/j.metabol.2025.156436_bb1150","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1038\/s41467-025-58634-4","article-title":"Correction of dysregulated lipid metabolism normalizes gene expression in oligodendrocytes and prolongs lifespan in female poly-GA C9orf72 mice","volume":"16","author":"Rezaei","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.metabol.2025.156436_bb1155","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.expneurol.2015.04.007","article-title":"Differential upregulation of the cannabinoid CB2 receptor in neurotoxic and inflammation-driven rat models of Parkinson\u2019s disease","volume":"269","author":"Concannon","year":"2015","journal-title":"Exp Neurol"},{"issue":"9","key":"10.1016\/j.metabol.2025.156436_bb1160","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2024.100614","article-title":"Discovering novel plasma biomarkers for ischemic stroke: lipidomic and metabolomic analyses in an aged mouse model","volume":"65","author":"Becktel","year":"2024","journal-title":"J Lipid Res"},{"issue":"1","key":"10.1016\/j.metabol.2025.156436_bb1165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015816","article-title":"Docosahexaenoic acid-derived neuroprotectin D1 induces neuronal survival via secretase- and PPAR\u03b3-mediated mechanisms in Alzheimer\u2019s disease models","volume":"6","author":"Zhao","year":"2011","journal-title":"PloS One"},{"issue":"6","key":"10.1016\/j.metabol.2025.156436_bb1170","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1046\/j.1460-9568.2003.02896.x","article-title":"Effects of levodopa on endocannabinoid levels in rat basal ganglia: implications for the treatment of levodopa-induced dyskinesias","volume":"18","author":"Ferrer","year":"2003","journal-title":"Eur J Neurosci"},{"issue":"12","key":"10.1016\/j.metabol.2025.156436_bb1175","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1007\/s00018-006-6037-3","article-title":"Endocannabinoids and beta-amyloid-induced neurotoxicity in vivo: effect of pharmacological elevation of endocannabinoid levels","volume":"63","author":"van der Stelt","year":"2006","journal-title":"Cell Mol Life Sci"},{"issue":"16","key":"10.1016\/j.metabol.2025.156436_bb1180","doi-asserted-by":"crossref","first-page":"6900","DOI":"10.1523\/JNEUROSCI.22-16-06900.2002","article-title":"Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission","volume":"22","author":"Gubellini","year":"2002","journal-title":"J Neurosci"},{"issue":"5","key":"10.1016\/j.metabol.2025.156436_bb1185","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3109\/10715762.2015.1005085","article-title":"LC\/MS analysis of cardiolipins in substantia nigra and plasma of rotenone-treated rats: implication for mitochondrial dysfunction in Parkinson\u2019s disease","volume":"49","author":"Tyurina","year":"2015","journal-title":"Free Radic Res"},{"key":"10.1016\/j.metabol.2025.156436_bb1190","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1476-511X-12-68","article-title":"Lipidomic analysis of brain tissues and plasma in a mouse model expressing mutated human amyloid precursor protein\/tau for Alzheimer\u2019s disease","volume":"12","author":"Tajima","year":"2013","journal-title":"Lipids Health Dis"},{"issue":"3","key":"10.1016\/j.metabol.2025.156436_bb1195","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.bbrc.2016.08.082","article-title":"LRRK2 deficiency impacts ceramide metabolism in brain","volume":"478","author":"Ferrazza","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"10.1016\/j.metabol.2025.156436_bb1200","doi-asserted-by":"crossref","first-page":"18865","DOI":"10.3390\/ijms160818865","article-title":"Major alterations of phosphatidylcholine and lysophosphotidylcholine lipids in the substantia nigra using an early stage model of Parkinson\u2019s disease","volume":"16","author":"Farmer","year":"2015","journal-title":"Int J Mol Sci"},{"issue":"12","key":"10.1016\/j.metabol.2025.156436_bb1205","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1038\/s41593-021-00944-z","article-title":"Multi-omic analysis of selectively vulnerable motor neuron subtypes implicates altered lipid metabolism in ALS","volume":"24","author":"Lee","year":"2022","journal-title":"Nat Neurosci"},{"issue":"4","key":"10.1016\/j.metabol.2025.156436_bb1210","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/s41593-025-01889-3","article-title":"Neuronal polyunsaturated fatty acids are protective in ALS\/FTD","volume":"28","author":"Giblin","year":"2025","journal-title":"Nat Neurosci"},{"issue":"5","key":"10.1016\/j.metabol.2025.156436_bb1215","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2023.100534","article-title":"Proteomic analysis of Huntington\u2019s disease medium spiny neurons identifies alterations in lipid droplets","volume":"22","author":"Tshilenge","year":"2023","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.metabol.2025.156436_bb1220","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102883","article-title":"Brain delivery of supplemental docosahexaenoic acid (DHA): a randomized placebo-controlled clinical trial","volume":"59","author":"Arellanes","year":"2020","journal-title":"EBioMedicine"},{"issue":"23","key":"10.1016\/j.metabol.2025.156436_bb1225","doi-asserted-by":"crossref","first-page":"5102","DOI":"10.3390\/nu14235102","article-title":"Extra-virgin olive oil enhances the blood-brain barrier function in mild cognitive impairment: a randomized controlled trial","volume":"14","author":"Kaddoumi","year":"2022","journal-title":"Nutrients"},{"issue":"7","key":"10.1016\/j.metabol.2025.156436_bb1230","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1016\/j.clnu.2019.10.017","article-title":"Medium-chain triglycerides improved cognition and lipid metabolomics in mild to moderate Alzheimer\u2019s disease patients with APOE4\u2212\/\u2212: a double-blind, randomized, placebo-controlled crossover trial","volume":"39","author":"Xu","year":"2019","journal-title":"Clin Nutr"},{"issue":"1","key":"10.1016\/j.metabol.2025.156436_bb1235","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13195-017-0286-2","article-title":"The medical food Souvenaid affects brain phospholipid metabolism in mild Alzheimer\u2019s disease: results from a randomized controlled trial","volume":"9","author":"Rijpma","year":"2017","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.metabol.2025.156436_bb1240","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13195-016-0173-2","article-title":"Double-blind, placebo-controlled, proof-of-concept trial of bexarotene Xin moderate Alzheimer\u2019s disease","volume":"8","author":"Cummings","year":"2016","journal-title":"Alzheimers Res Ther"},{"issue":"3","key":"10.1016\/j.metabol.2025.156436_bb1245","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.3233\/JAD-190864","article-title":"An exploratory phase IIa study of the PPAR delta\/gamma agonist T3D-959 assessing metabolic and cognitive function in subjects with mild to moderate Alzheimer\u2019s disease","volume":"73","author":"Chamberlain","year":"2020","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"10.1016\/j.metabol.2025.156436_bb1250","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1186\/s12944-024-02398-1","article-title":"Effects of Probucol on plasma amyloid-\u03b2 transport in patients with hyperlipidemia: a 12-week randomized, double-blind, placebo-controlled trial","volume":"23","author":"Dang","year":"2024","journal-title":"Lipids Health Dis"},{"issue":"4","key":"10.1016\/j.metabol.2025.156436_bb1255","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.maturitas.2004.08.004","article-title":"Effect of raloxifene and hormone therapy on serum markers of brain and whole-body cholesterol metabolism in postmenopausal women","volume":"50","author":"Vogelvang","year":"2004","journal-title":"Maturitas"},{"issue":"2","key":"10.1016\/j.metabol.2025.156436_bb1260","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3233\/JPD-212714","article-title":"Safety, pharmacokinetics, and pharmacodynamics of oral venglustat in patients with Parkinson\u2019s disease and a GBA mutation: results from part 1 of the randomized, double-blinded, placebo-controlled MOVES-PD trial","volume":"12","author":"Peterschmitt","year":"2022","journal-title":"J Parkinsons Dis"},{"issue":"8","key":"10.1016\/j.metabol.2025.156436_bb1265","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S1474-4422(23)00205-3","article-title":"Safety and efficacy of venglustat in GBA1-associated Parkinson\u2019s disease: an international, multicentre, double-blind, randomised, placebo-controlled, phase 2 trial","volume":"22","author":"Giladi","year":"2023","journal-title":"Lancet Neurol"},{"issue":"7","key":"10.1016\/j.metabol.2025.156436_bb1270","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1002\/mds.29346","article-title":"A phase 1B trial in GBA1-associated Parkinson\u2019s disease of BIA-28-6156, a glucocerebrosidase activator","volume":"38","author":"den Heijer","year":"2023","journal-title":"Mov Disord"},{"issue":"6","key":"10.1016\/j.metabol.2025.156436_bb1275","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.stem.2023.04.017","article-title":"Phase 1\/2a clinical trial in ALS with ropinirole, a drug candidate identified by iPSC drug discovery","volume":"30","author":"Morimoto","year":"2023","journal-title":"Cell Stem Cell"},{"issue":"12","key":"10.1016\/j.metabol.2025.156436_bb1280","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.1111\/ene.16020","article-title":"A randomized, double-blind, placebo-controlled phase 2 study to assess safety, tolerability, and efficacy of RT001 in patients with amyotrophic lateral sclerosis","volume":"30","author":"Weemering","year":"2023","journal-title":"Eur J Neurol"},{"issue":"4","key":"10.1016\/j.metabol.2025.156436_bb1285","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/brain\/awz382","article-title":"Lipid metabolic pathways converge in motor neuron degenerative diseases","volume":"143","author":"Rickman","year":"2020","journal-title":"Brain"},{"issue":"10","key":"10.1016\/j.metabol.2025.156436_bb1290","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1093\/brain\/awab292","article-title":"Effects of statins on dopamine loss and prognosis in Parkinson\u2019s disease","volume":"144","author":"Jeong","year":"2021","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.metabol.2025.156436_bb1295","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jalz.2008.02.001","article-title":"The Atorvastatin\/Donepezil in Alzheimer\u2019s Disease Study (LEADe): design and baseline characteristics","volume":"4","author":"Jones","year":"2008","journal-title":"Alzheimers Dement"},{"issue":"3","key":"10.1016\/j.metabol.2025.156436_bb1300","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1002\/alz.13543","article-title":"Statin use moderates APOE\u2019s and CRP\u2019s associations with dementia and is associated with lesser dementia severity in \u03b54 carriers","volume":"20","author":"Royall","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"4","key":"10.1016\/j.metabol.2025.156436_bb1305","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1002\/anie.201204964","article-title":"Alzheimer\u2019s disease, cholesterol, and statins: the junctions of important metabolic pathways","volume":"52","author":"Silva","year":"2013","journal-title":"Angew Chem Int Ed Engl"},{"issue":"8","key":"10.1016\/j.metabol.2025.156436_bb1310","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1093\/brain\/awac186","article-title":"Genetically predicted on-statin LDL response is associated with higher intracerebral haemorrhage risk","volume":"145","author":"Mayerhofer","year":"2022","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.metabol.2025.156436_bb1315","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s12035-014-9030-0","article-title":"Atorvastatin protects NSC-34 motor neurons against oxidative stress by activating PI3K, ERK and free radical scavenging","volume":"53","author":"Lee","year":"2016","journal-title":"Mol Neurobiol"},{"issue":"2","key":"10.1016\/j.metabol.2025.156436_bb1320","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1021\/acs.molpharmaceut.8b00096","article-title":"Retinoid X receptor alpha nitro-ligand Z-10 and its optimized derivative Z-36 reduce \u03b2-amyloid plaques in Alzheimer\u2019s disease mouse model","volume":"16","author":"Ren","year":"2019","journal-title":"Mol Pharm"},{"issue":"2","key":"10.1016\/j.metabol.2025.156436_bb1325","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1161\/STROKEAHA.116.015592","article-title":"ABCA1\/ApoE\/HDL pathway mediates GW3965-induced neurorestoration after stroke","volume":"248","author":"Cui","year":"2017","journal-title":"Stroke"},{"key":"10.1016\/j.metabol.2025.156436_bb1330","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1750-1326-5-44","article-title":"Systemic treatment with liver X receptor agonists raises apolipoprotein E, cholesterol, and amyloid-\u03b2 peptides in the cerebral spinal fluid of rats","volume":"5","author":"Suon","year":"2010","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.metabol.2025.156436_bb1335","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.117895","article-title":"Liver-X receptor \u03b2-selective agonist CE9A215 regulates Alzheimer\u2019s disease-associated pathology in a 3xTg-AD mouse model","volume":"184","author":"Ban","year":"2025","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"10.1016\/j.metabol.2025.156436_bb1340","doi-asserted-by":"crossref","first-page":"4678","DOI":"10.1021\/acsnano.0c09159","article-title":"Liver X receptor activation with an intranasal polymer therapeutic prevents cognitive decline without altering lipid levels","volume":"15","author":"Navas Guimaraes","year":"2021","journal-title":"ACS Nano"},{"issue":"4","key":"10.1016\/j.metabol.2025.156436_bb1345","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.cmet.2013.03.009","article-title":"Impaired cholesterol efflux in senescent macrophages promotes age-related macular degeneration","volume":"17","author":"Sene","year":"2013","journal-title":"Cell Metab"},{"issue":"1","key":"10.1016\/j.metabol.2025.156436_bb1350","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s13195-023-01353-z","article-title":"A novel apoE-mimetic increases brain apoE levels, reduces A\u03b2 pathology and improves memory when treated before onset of pathology in male mice that express APOE3","volume":"15","author":"Valencia-Olvera","year":"2023","journal-title":"Alzheimers Res Ther"},{"issue":"13","key":"10.1016\/j.metabol.2025.156436_bb1355","article-title":"Stealth liposomes encapsulating a potent ACAT1\/SOAT1 inhibitor F12511: pharmacokinetic, biodistribution, and toxicity studies in wild-type mice and efficacy studies in triple transgenic Alzheimer\u2019s disease mice","volume":"24","author":"De","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.metabol.2025.156436_bb1360","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.neuron.2004.08.043","article-title":"The ACAT inhibitor CP-113,818 markedly reduces amyloid pathology in a mouse model of Alzheimer\u2019s disease","volume":"44","author":"Hutter-Paier","year":"2004","journal-title":"Neuron"},{"issue":"10","key":"10.1016\/j.metabol.2025.156436_bb1365","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.3390\/biom14101301","article-title":"Inhibiting the cholesterol storage enzyme ACAT1\/SOAT1 in myelin debris-treated microglial cell lines activates the gene expression of cholesterol efflux transporter ABCA1","volume":"214","author":"Huynh","year":"2024","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/j.metabol.2025.156436_bb1370","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3233\/JAD-161175","article-title":"The Anti-Amyloid-\u03b2 and Neuroprotective Properties of a Novel Tricyclic Pyrone Molecule","volume":"58","author":"Maezawa","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.metabol.2025.156436_bb1375","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2019.109793","article-title":"Neuroprotective effect of PPAR alpha and gamma agonists in a mouse model of amyloidogenesis through modulation of the Wnt\/beta catenin pathway via targeting alpha- and beta-secretases","volume":"97","author":"Assaf","year":"2020","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"2","key":"10.1016\/j.metabol.2025.156436_bb1380","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1523\/JNEUROSCI.0933-21.2021","article-title":"Repeated administration of 2-hydroxypropyl-\u03b2-cyclodextrin (HP\u03b2CD) attenuates the chronic inflammatory response to experimental stroke","volume":"42","author":"Becktel","year":"2022","journal-title":"J Neurosci"},{"issue":"50","key":"10.1016\/j.metabol.2025.156436_bb1385","doi-asserted-by":"crossref","first-page":"33792","DOI":"10.1021\/acsnano.4c11966","article-title":"Recent progress in nanomedicine for the diagnosis and treatment of Alzheimer\u2019s diseases","volume":"18","author":"Yang","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.metabol.2025.156436_bb1390","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.plipres.2015.12.003","article-title":"The role of omega-3 polyunsaturated fatty acids eicosapentaenoic and docosahexaenoic acids in the treatment of major depression and Alzheimer\u2019s disease: acting separately or synergistically?","volume":"62","author":"Song","year":"2016","journal-title":"Prog Lipid Res"},{"issue":"573","key":"10.1016\/j.metabol.2025.156436_bb1395","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb1206","article-title":"An epoxide hydrolase inhibitor reduces neuroinflammation in a mouse model of Alzheimer\u2019s disease","volume":"12","author":"Ghosh","year":"2024","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.metabol.2025.156436_bb1400","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pbb.2016.04.002","article-title":"Modulation of LOX and COX pathways via inhibition of amyloidogenesis contributes to mitoprotection against \u03b2-amyloid oligomer-induced toxicity in an animal model of Alzheimer\u2019s disease in rats","volume":"146-147","author":"Kalra","year":"2016","journal-title":"Pharmacol Biochem Behav"},{"issue":"2","key":"10.1016\/j.metabol.2025.156436_bb1405","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/sj.mp.4001773","article-title":"Inhibition of cyclooxygenase as potential novel therapeutic strategy in N141I presenilin-2 familial Alzheimer\u2019s disease","volume":"11","author":"Qin","year":"2006","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.metabol.2025.156436_bb1410","article-title":"Iron dyshomeostasis and ferroptosis in Alzheimer\u2019s disease: molecular mechanisms of cell death and novel therapeutic drugs and targets for AD","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.metabol.2025.156436_bb1415","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.freeradbiomed.2024.03.019","article-title":"Edaravone dexborneol protects against cerebral ischemia\/reperfusion-induced blood-brain barrier damage by inhibiting ferroptosis via activation of nrf-2\/HO-1\/GPX4 signaling","volume":"217","author":"Xiao","year":"2024","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.metabol.2025.156436_bb1420","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101648","article-title":"CMS121, a fatty acid synthase inhibitor, protects against excess lipid peroxidation and inflammation and alleviates cognitive loss in a transgenic mouse model of Alzheimer\u2019s disease","volume":"36","author":"Ates","year":"2020","journal-title":"Redox Biol"},{"issue":"4","key":"10.1016\/j.metabol.2025.156436_bb1425","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/mus.27672","article-title":"An expanded access protocol of RT001 in amyotrophic lateral sclerosis-Initial experience with a lipid peroxidation inhibitor","volume":"66","author":"Yerton","year":"2022","journal-title":"Muscle Nerve"},{"issue":"5","key":"10.1016\/j.metabol.2025.156436_bb1430","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S1474-4422(19)30032-8","article-title":"Safety, efficacy, and mechanisms of action of cannabinoids in neurological disorders","volume":"18","author":"Friedman","year":"2019","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.metabol.2025.156436_bb1435","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.brainres.2013.06.014","article-title":"Cerebroprotective effects of TAK-937, a novel cannabinoid receptor agonist, in permanent and thrombotic focal cerebral ischemia in rats: therapeutic time window, combination with t-PA and efficacy in aged rats","volume":"1526","author":"Murakami","year":"2013","journal-title":"Brain Res"},{"key":"10.1016\/j.metabol.2025.156436_bb1440","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1146\/annurev.cellbio.21.122303.120624","article-title":"Docosahexaenoic acid, fatty acid-interacting proteins, and neuronal function: breastmilk and fish are good for you","volume":"21","author":"Marszalek","year":"2005","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"11","key":"10.1016\/j.metabol.2025.156436_bb1445","doi-asserted-by":"crossref","first-page":"578","DOI":"10.3390\/md21110578","article-title":"Algae food products as a healthcare solution","volume":"21","author":"Tavares","year":"2023","journal-title":"Mar Drugs"},{"issue":"10","key":"10.1016\/j.metabol.2025.156436_bb1450","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1002\/jnr.23090","article-title":"Deficiency of ganglioside GM1 correlates with Parkinson\u2019s disease in mice and humans","volume":"90","author":"Wu","year":"2012","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.metabol.2025.156436_bb1455","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.mcn.2016.06.009","article-title":"Anti-amyloidogenic effects of glycosphingolipid synthesis inhibitors occur independently of ganglioside alterations","volume":"75","author":"Noel","year":"2016","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.metabol.2025.156436_bb1460","doi-asserted-by":"crossref","DOI":"10.1038\/s41401-025-01505-x","article-title":"MMP-9 inhibitor SB-3CT improves neurological outcomes in ischemic stroke mice by modulation of astrocytic lipid metabolism","author":"Du","year":"2025","journal-title":"Acta Pharmacol Sin"},{"issue":"11","key":"10.1016\/j.metabol.2025.156436_bb1465","doi-asserted-by":"crossref","first-page":"6028","DOI":"10.1021\/acs.jmedchem.0c00278","article-title":"Novel human neutral sphingomyelinase 2 inhibitors as potential therapeutics for Alzheimer\u2019s disease","volume":"63","author":"\u0160\u00e1la","year":"2020","journal-title":"J Med Chem"},{"issue":"1","key":"10.1016\/j.metabol.2025.156436_bb1470","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00401-024-02759-1","article-title":"Co-registration of MALDI-MSI and histology demonstrates gangliosides co-localize with amyloid beta plaques in Alzheimer\u2019s disease","volume":"147","author":"Ollen-Bittle","year":"2024","journal-title":"Acta Neuropathol"},{"issue":"1","key":"10.1016\/j.metabol.2025.156436_bb1475","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1021\/acschemneuro.8b00406","article-title":"Ganglioside Hp-s1 analogue inhibits amyloidogenic toxicity in Alzheimer\u2019s disease model cells","volume":"10","author":"Tsai","year":"2019","journal-title":"ACS Chem Nerosci"},{"issue":"1","key":"10.1016\/j.metabol.2025.156436_bb1480","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13195-022-00966-0","article-title":"Glucosylceramide synthase inhibition reduces ganglioside GM3 accumulation, alleviates amyloid neuropathology, and stabilizes remote contextual memory in a mouse model of Alzheimer\u2019s disease","volume":"14","author":"Dodge","year":"2022","journal-title":"Alzheimers Res Ther"},{"issue":"11","key":"10.1016\/j.metabol.2025.156436_bb1485","doi-asserted-by":"crossref","first-page":"10801","DOI":"10.1021\/acsnano.5b03124","article-title":"GM1-modified lipoprotein-like nanoparticle: multifunctional nanoplatform for the combination therapy of Alzheimer\u2019s disease","volume":"9","author":"Huang","year":"2015","journal-title":"ACS Nano"},{"issue":"3","key":"10.1016\/j.metabol.2025.156436_bb1490","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/CIRCRESAHA.120.316711","article-title":"Endothelial S1P1 signaling counteracts infarct expansion in ischemic stroke","volume":"128","author":"Nitzsche","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.metabol.2025.156436_bb1495","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113240","article-title":"FTY720 decreases ceramides levels in the brain and prevents memory impairments in a mouse model of familial Alzheimer\u2019s disease expressing APOE4","volume":"152","author":"Crivelli","year":"2022","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10.1016\/j.metabol.2025.156436_bb1500","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s12035-018-1040-x","article-title":"Modulatory effects of fingolimod (FTY720) on the expression of sphingolipid metabolism-related genes in an animal model of Alzheimer\u2019s disease","volume":"56","author":"J\u0119\u015bko","year":"2019","journal-title":"Mol Neurobiol"},{"issue":"6","key":"10.1016\/j.metabol.2025.156436_bb1505","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1007\/s12035-020-01908-3","article-title":"Fingolimod affects transcription of genes encoding enzymes of ceramide metabolism in animal model of Alzheimer\u2019s disease","volume":"57","author":"J\u0119\u015bko","year":"2020","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.metabol.2025.156436_bb1510","doi-asserted-by":"crossref","DOI":"10.1016\/j.jare.2025.02.012","article-title":"Blocking S1P4 signaling attenuates brain injury in mice with ischemic stroke","author":"Basnet","year":"2025","journal-title":"J Adv Res"},{"issue":"12","key":"10.1016\/j.metabol.2025.156436_bb1515","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1161\/STROKEAHA.116.015371","article-title":"Selective sphingosine 1-phosphate receptor 1 agonist is protective against ischemia\/reperfusion in mice","volume":"47","author":"Brait","year":"2016","journal-title":"Stroke"},{"issue":"14","key":"10.1016\/j.metabol.2025.156436_bb1520","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1093\/hmg\/ddy153","article-title":"Stimulation of S1PR5 with A-971432, a selective agonist, preserves blood-brain barrier integrity and exerts therapeutic effect in an animal model of Huntington\u2019s disease","volume":"27","author":"Di Pardo","year":"2018","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.1016\/j.metabol.2025.156436_bb1525","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ymthe.2022.09.004","article-title":"Treatment with THI, an inhibitor of sphingosine-1-phosphate lyase, modulates glycosphingolipid metabolism and results therapeutically effective in experimental models of Huntington\u2019s disease","volume":"31","author":"Martinello","year":"2023","journal-title":"Mol Ther"},{"issue":"1","key":"10.1016\/j.metabol.2025.156436_bb1530","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/mp.2014.135","article-title":"Evidence that small molecule enhancement of \u03b2-hexosaminidase activity corrects the behavioral phenotype in Dutch APP(E693Q) mice through reduction of ganglioside-bound A\u03b2","volume":"20","author":"Knight","year":"2015","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.metabol.2025.156436_bb1535","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155101","article-title":"Natural products for the treatment of neurodegenerative diseases","volume":"121","author":"Cui","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.metabol.2025.156436_bb1540","doi-asserted-by":"crossref","DOI":"10.1038\/srep18736","article-title":"Curcumin modulates cell death and is protective in Huntington\u2019s disease model","volume":"6","author":"Chongtham","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.metabol.2025.156436_bb1545","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2023.101256","article-title":"Effects of DHA on cognitive dysfunction in aging and Alzheimer\u2019s disease: the mediating roles of ApoE","volume":"93","author":"Zhang","year":"2024","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.metabol.2025.156436_bb1550","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101107","article-title":"NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis","volume":"23","author":"Dodson","year":"2019","journal-title":"Redox Biol"},{"issue":"5","key":"10.1016\/j.metabol.2025.156436_bb1555","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1142\/S0192415X13500699","article-title":"Curcumin induces ABCA1 expression and apolipoprotein A-I-mediated cholesterol transmembrane in the chronic cerebral hypoperfusion aging rats","volume":"41","author":"Tian","year":"2013","journal-title":"Am J Chin Med"},{"issue":"3","key":"10.1016\/j.metabol.2025.156436_bb1560","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3233\/JHD-160204","article-title":"Therapeutic effects of anthocyanins and environmental enrichment in R6\/1 Huntington\u2019s disease mice","volume":"5","author":"Kreilaus","year":"2016","journal-title":"J Huntingtons Dis"},{"issue":"5","key":"10.1016\/j.metabol.2025.156436_bb1565","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1021\/jf103822h","article-title":"Protective effects of anthocyanins against amyloid \u03b2-peptide-induced damage in neuro-2A cells","volume":"59","author":"Shih","year":"2011","journal-title":"J Agric Food Chem"},{"issue":"s1","key":"10.1016\/j.metabol.2025.156436_bb1570","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.3233\/JAD-161034","article-title":"Resveratrol intervenes cholesterol- and isoprenoid-mediated amyloidogenic processing of A\u03b2PP in familial Alzheimer\u2019s disease","volume":"60","author":"Sathya","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.metabol.2025.156436_bb1575","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.118205","article-title":"Ginsenoside Rg1 alleviates chronic inflammation-induced neuronal ferroptosis and cognitive impairments via regulation of AIM2 - Nrf2 signaling pathway","volume":"330","author":"Kong","year":"2024","journal-title":"J Ethnopharmacol"},{"issue":"16","key":"10.1016\/j.metabol.2025.156436_bb1580","doi-asserted-by":"crossref","first-page":"6161","DOI":"10.7150\/thno.98172","article-title":"A novel ferroptosis inhibitor, Thonningianin A, improves Alzheimer's disease by activating GPX4","volume":"14","author":"Yong","year":"2024","journal-title":"Theranostics"},{"issue":"5","key":"10.1016\/j.metabol.2025.156436_bb1585","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1142\/S0192415X16500518","article-title":"Berberine preconditioning protects neurons against ischemia via sphingosine-1-phosphate and hypoxia-inducible factor-1[formula: see text]","volume":"244","author":"Zhang","year":"2016","journal-title":"Am J Chin Med"},{"key":"10.1016\/j.metabol.2025.156436_bb1590","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.124316","article-title":"Resveratrol-loaded selenium\/chitosan nano-flowers alleviate glucolipid metabolism disorder-associated cognitive impairment in Alzheimer\u2019s disease","volume":"239","author":"Yang","year":"2023","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.metabol.2025.156436_bb1595","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154762","article-title":"Salidroside alleviates cognitive impairment by inhibiting ferroptosis via activation of the Nrf2\/GPX4 axis in SAMP8 mice","volume":"114","author":"Yang","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.metabol.2025.156436_bb1600","doi-asserted-by":"crossref","first-page":"10453","DOI":"10.2147\/IJN.S272831","article-title":"Polymeric nanoparticles-based brain delivery with improved therapeutic efficacy of ginkgolide B in Parkinson\u2019s disease","volume":"15","author":"Zhao","year":"2020","journal-title":"Int J Nanomedicine"},{"issue":"7","key":"10.1016\/j.metabol.2025.156436_bb1605","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.2174\/1570159X19666210712152532","article-title":"Curcumin, resveratrol and cannabidiol as natural key prototypes in drug design for neuroprotective agents","volume":"20","author":"Viegas","year":"2022","journal-title":"Curr Neuropharmacol"},{"issue":"36","key":"10.1016\/j.metabol.2025.156436_bb1610","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.1039\/D3AY00899A","article-title":"Serum lipidomics reveal the mechanism of memory disorder improvement by Qifu decoction","volume":"15","author":"Deng","year":"2023","journal-title":"Anal Methods"},{"key":"10.1016\/j.metabol.2025.156436_bb1615","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2023.115610","article-title":"Efficacy evaluation and metabolomics analysis of Huanglian Jiedu decoction in combination with donepezil for Alzheimer\u2019s disease treatment","volume":"235","author":"Xu","year":"2023","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.metabol.2025.156436_bb1620","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.2147\/DDDT.S462266","article-title":"Chuanxiong renshen decoction inhibits Alzheimer\u2019s disease neuroinflammation by regulating PPAR\u03b3\/NF-\u03baB pathway","volume":"18","author":"Hou","year":"2024","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.metabol.2025.156436_bb1625","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115491","article-title":"LiuweiDihuang improved cognitive functions in SAMP8 mice by inhibiting COX-2 expression and subsequent neuroinflammation","volume":"296","author":"Song","year":"2022","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.metabol.2025.156436_bb1630","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2022.116651","article-title":"Integrated lipidomics and network pharmacology analysis of the protective effects and mechanism of Yuanzhi San on rats with cognitive impairment","volume":"58","author":"Wang","year":"2022","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.metabol.2025.156436_bb1635","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.112824","article-title":"Tianma Gouteng granules decreases the susceptibility of Parkinson\u2019s disease by inhibiting ALOX15-mediated lipid peroxidation","volume":"256","author":"Jiang","year":"2020","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.metabol.2025.156436_bb1640","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.117679","article-title":"SuanZaoRen decoction alleviates neuronal loss, synaptic damage and ferroptosis of AD via activating DJ-1\/Nrf2 signaling pathway","volume":"323","author":"Long","year":"2024","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"10.1016\/j.metabol.2025.156436_bb1645","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3233\/JAD-220556","article-title":"Supplementation with carotenoids, omega-3 fatty acids, and vitamin e has a positive effect on the symptoms and progression of Alzheimer\u2019s disease","volume":"90","author":"Nolan","year":"2022","journal-title":"J Alzheimers Dis"},{"issue":"15","key":"10.1016\/j.metabol.2025.156436_bb1650","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.3390\/nu15153454","article-title":"Polyphenols and their impact on the prevention of neurodegenerative diseases and development","volume":"15","author":"Grabska-Koby\u0142ecka","year":"2023","journal-title":"Nutrients"},{"issue":"11","key":"10.1016\/j.metabol.2025.156436_bb1655","doi-asserted-by":"crossref","first-page":"4256","DOI":"10.1021\/acs.molpharmaceut.0c00675","article-title":"In vitro and in vivo comparison of curcumin-encapsulated chitosan-coated poly(lactic-co-glycolic acid) nanoparticles and curcumin\/hydroxypropyl-\u03b2-cyclodextrin inclusion complexes administered intranasally as therapeutic strategies for Alzheimer\u2019s disease","volume":"17","author":"Zhang","year":"2020","journal-title":"Mol Pharm"},{"key":"10.1016\/j.metabol.2025.156436_bb1660","doi-asserted-by":"crossref","DOI":"10.1017\/S2045796022000567","article-title":"Adherence to dietary guidelines and risk of dementia: a prospective cohort study of 94 184 individuals","volume":"31","author":"Kjeldsen","year":"2022","journal-title":"Epidemiol Psychiatr Sci"},{"issue":"4","key":"10.1016\/j.metabol.2025.156436_bb1665","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13213","article-title":"In situ analysis of acupuncture protecting dopaminergic neurons from lipid peroxidative damage in mice of Parkinson\u2019s disease","volume":"55","author":"Zuo","year":"2022","journal-title":"Cell Prolif"},{"issue":"12","key":"10.1016\/j.metabol.2025.156436_bb1670","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.jnutbio.2004.06.008","article-title":"Ginkgo biloba extract (Egb 761) inhibits beta-amyloid production by lowering free cholesterol levels","volume":"15","author":"Yao","year":"2004","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.metabol.2025.156436_bb1675","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.phymed.2018.04.009","article-title":"Anti-neuroinflammatory effects of Ginkgo biloba extract EGb761 in LPS-activated primary microglial cells","volume":"44","author":"Gargouri","year":"2018","journal-title":"Phytomedicine"},{"issue":"23","key":"10.1016\/j.metabol.2025.156436_bb1680","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.3390\/cells12232672","article-title":"Assessing cannabidiol as a therapeutic agent for preventing and alleviating Alzheimer's disease neurodegeneration","volume":"12","author":"Chen","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.metabol.2025.156436_bb1685","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.freeradbiomed.2024.08.031","article-title":"Icariin targets p53 to protect against ceramide-induced neuronal senescence: implication in Alzheimer\u2019s disease","volume":"224","author":"Wu","year":"2024","journal-title":"Free Radic Biol Med"},{"issue":"9","key":"10.1016\/j.metabol.2025.156436_bb1690","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.3390\/antiox10091448","article-title":"Lutein as a modulator of oxidative stress-mediated inflammatory diseases","volume":"10","author":"Ahn","year":"2021","journal-title":"Antioxidants (Basel)"},{"issue":"4","key":"10.1016\/j.metabol.2025.156436_bb1695","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3109\/10715762.2014.885117","article-title":"Notoginsenoside R1-mediated neuroprotection involves estrogen receptor-dependent crosstalk between Akt and ERK1\/2 pathways: a novel mechanism of Nrf2\/ARE signaling activation","volume":"48","author":"Meng","year":"2014","journal-title":"Free Radic Res"},{"key":"10.1016\/j.metabol.2025.156436_bb1700","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.176264","article-title":"Quercetin attenuates cerebral ischemic injury by inhibiting ferroptosis via Nrf2\/HO-1 signaling pathway","volume":"963","author":"Peng","year":"2024","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"10.1016\/j.metabol.2025.156436_bb1705","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/s41401-024-01378-6","article-title":"Artemisinin inhibits neuronal ferroptosis in Alzheimer\u2019s disease models by targeting KEAP1","volume":"46","author":"Deng","year":"2025","journal-title":"Acta Pharmacol Sin"},{"issue":"5","key":"10.1016\/j.metabol.2025.156436_bb1710","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1002\/ptr.8152","article-title":"Curculigoside, a traditional Chinese medicine monomer, ameliorates oxidative stress in Alzheimer\u2019s disease mouse model via suppressing ferroptosis","volume":"38","author":"Gong","year":"2024","journal-title":"Phytother Res"},{"issue":"4","key":"10.1016\/j.metabol.2025.156436_bb1715","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035823","article-title":"Diammonium glycyrrhizinate upregulates PGC-1\u03b1 and protects against A\u03b21-42-induced neurotoxicity","volume":"7","author":"Zhu","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.metabol.2025.156436_bb1720","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.intimp.2017.08.014","article-title":"Esculentoside A exerts anti-inflammatory activity in microglial cells","volume":"51","author":"Yang","year":"2017","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.metabol.2025.156436_bb1725","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101911","article-title":"Kaempferol alleviates LD-mitochondrial damage by promoting autophagy: implications in Parkinson\u2019s disease","volume":"41","author":"Han","year":"2021","journal-title":"Redox Biol"},{"key":"10.1016\/j.metabol.2025.156436_bb1730","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2025.119335","article-title":"Lignans from Schisandra chinensis (Turcz.) Baill ameliorates cognitive impairment in Alzheimer\u2019s disease and alleviates ferroptosis by activating the Nrf2\/FPN1 signaling pathway and regulating iron levels","volume":"341","author":"Meng","year":"2025","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.metabol.2025.156436_bb1735","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.109886","article-title":"Magnolol alleviates Alzheimer\u2019s disease-like pathology in transgenic C. elegans by promoting microglia phagocytosis and the degradation of beta-amyloid through activation of PPAR-\u03b3","volume":"124","author":"Xie","year":"2020","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10.1016\/j.metabol.2025.156436_bb1740","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12974-019-1515-3","article-title":"Malva parviflora extract ameliorates the deleterious effects of a high fat diet on the cognitive deficit in a mouse model of Alzheimer\u2019s disease by restoring microglial function via a PPAR-\u03b3-dependent mechanism","volume":"16","author":"Medrano-Jim\u00e9nez","year":"2019","journal-title":"J Neuroinflammation"},{"issue":"1","key":"10.1016\/j.metabol.2025.156436_bb1745","article-title":"Myricetin mitigates motor disturbance and decreases neuronal ferroptosis in a rat model of Parkinson\u2019s disease","volume":"14","author":"Gu","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.metabol.2025.156436_bb1750","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.177075","article-title":"Proteomic alteration in catalpol treatment of Alzheimer\u2019s disease by regulating HSPA5\/GPX4","volume":"987","author":"Tian","year":"2025","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.metabol.2025.156436_bb1755","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.biopha.2015.10.004","article-title":"Safflower yellow reduces lipid peroxidation, neuropathology, tau phosphorylation and ameliorates amyloid \u03b2-induced impairment of learning and memory in rats","volume":"76","author":"Ma","year":"2015","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.metabol.2025.156436_bb1760","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.113468","article-title":"Sesame oil mitigates memory impairment, oxidative stress, and neurodegeneration in a rat model of Alzheimer\u2019s disease. A pivotal role of NF-\u03baB\/p38MAPK\/BDNF\/PPAR-\u03b3 pathways","volume":"267","author":"Mohamed","year":"2021","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.metabol.2025.156436_bb1765","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108277","article-title":"Volatile oils of Schisandra chinensis (Turcz.) Baill alleviates Parkinson\u2019s disease by activating the Nrf2 pathway to positively regulate autophagy and oxidative stress","volume":"157","author":"Wang","year":"2025","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.metabol.2025.156436_bb1770","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.156275","article-title":"Wolfberry (Lycium barbarum) glycopeptide attenuates dopaminergic neurons loss by inhibiting lipid peroxidation in Parkinson\u2019s disease","volume":"136","author":"Lin","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.metabol.2025.156436_bb1775","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2020.135455","article-title":"Mini review: lipids in peripheral nerve disorders","volume":"740","author":"Hornemann","year":"2021","journal-title":"Neurosci Lett"},{"issue":"10","key":"10.1016\/j.metabol.2025.156436_bb1780","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1161\/STROKEAHA.121.034576","article-title":"Lipid-lowering therapy and hemorrhagic stroke risk: comparative meta-analysis of statins and PCSK9 inhibitors","volume":"52","author":"Sanz-Cuesta","year":"2021","journal-title":"Stroke"},{"issue":"25","key":"10.1016\/j.metabol.2025.156436_bb1785","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1016\/j.jacc.2021.04.075","article-title":"Effect of statin therapy on cognitive decline and incident dementia in older adults","volume":"77","author":"Zhou","year":"2021","journal-title":"J Am Coll Cardiol"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049525003051?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049525003051?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T04:23:43Z","timestamp":1781065423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049525003051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":357,"alternative-id":["S0026049525003051"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2025.156436","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting lipid metabolism in neurodegenerative diseases: From experimental to clinical","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2025.156436","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156436"}}